WO1992013451A1 - Imidazole pesticides - Google Patents

Imidazole pesticides Download PDF

Info

Publication number
WO1992013451A1
WO1992013451A1 PCT/GB1992/000233 GB9200233W WO9213451A1 WO 1992013451 A1 WO1992013451 A1 WO 1992013451A1 GB 9200233 W GB9200233 W GB 9200233W WO 9213451 A1 WO9213451 A1 WO 9213451A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
dichloro
formula
optionally substituted
trifluoromethylphenyl
Prior art date
Application number
PCT/GB1992/000233
Other languages
French (fr)
Inventor
Robert John Willis
Mary Josephine O'mahony
Bryan Glyn Roberts
Ian David Marlow
Ian Kenneth Boddy
Original Assignee
Schering Agrochemicals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919102834A external-priority patent/GB9102834D0/en
Priority claimed from GB919102835A external-priority patent/GB9102835D0/en
Priority claimed from GB919102848A external-priority patent/GB9102848D0/en
Priority claimed from GB919102847A external-priority patent/GB9102847D0/en
Priority claimed from GB919102857A external-priority patent/GB9102857D0/en
Priority claimed from GB919102841A external-priority patent/GB9102841D0/en
Priority claimed from GB919102838A external-priority patent/GB9102838D0/en
Priority claimed from GB919114712A external-priority patent/GB9114712D0/en
Priority claimed from GB919117822A external-priority patent/GB9117822D0/en
Application filed by Schering Agrochemicals Limited filed Critical Schering Agrochemicals Limited
Publication of WO1992013451A1 publication Critical patent/WO1992013451A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • This invention relates to new imidazoles having pesticidal and especially insecticidal, acaricidal and animal endoparasiticidal activity.
  • the bulk of the compounds have a priority date earlier than the publication date of EP 412 849.
  • the ⁇ prior art disclosed..in that application is incorporated by reference.
  • Y is O, S or N 12.
  • w 4 is C or can also be S when Y is 0;
  • A is S(0) m , 0 or NR 13 ;
  • R 1 and R 2 are hydrogen, optionally substituted alkyl, cyano, halogen or nitro;
  • R 3 is hydrogen, optionally substituted alkyl, acyl, optionally substituted alkoxycarbonyl or sulfamoyl;
  • R 5 is hydrogen, halogen, optionally substituted alkyl, optionally substituted alkoxy, -NR 16 R 17 , cyano, nitro, S0 2 NR 16 R 17 , CYNR 16 R 17 , COOR 18 or R 19 S(0) m ;
  • R 4 and R 10 which may be the same or different, are hydrogen, halogen, hydroxy, mercapto, cyano, nitro, optionally substituted alkyl, optionally substituted alkoxy, -NR 16 R 17 , -S0 2 NR 16 R 17 , CHO, CH 2 OH, COOR 18 or
  • R _6° is substituted alkyl, hydroxy, alkoxy, haloalkoxy, cyano, nitro, R 19 S(0) m or an N-linked 5-membered heteroaryl group containing 1-4 nitrogen atoms; and when R 5 is cyano, -CYNR 16 R 17 , -COOR 18 , optionally substituted alkoxy, nitro, -NR 16 R 17 or _S0 2 NR 16 R 17 , R 6 . can also be hydrogen, halogen, alkyl or -NR 16 R 17 ; R 7 , R 8 and R 11 , which may be the same or different, are hydrogen, halogen, optionally substituted alkyl or optionally substituted alkylthio;
  • R 9 is hydrogen, halogen, optionally substituted alkyl, for yl, optionally substitutjed_alkoxy r aryl., cyano, nitro, hydroxy, trialkylsilyloxy, CYNR 16 R 17 , COOR 18 or R 19 S(0) m ;
  • R 12 is hydrogen, optionally substituted alkyl or acyl
  • R 13 is hydrogen, alkyl or acyl
  • R 16 and R 17 are the same or different and are hydrogen, optionally substituted alkyl, acyl or aryl, or together with the nitrogen to which they are attached, form a 5 to 7 membered ring which can contain other hetero atoms;
  • R 18 is hydrogen or optionally substituted alkyl
  • R 19 is optionally substituted alkyl
  • R 40 is hydrogen, optionally substituted alkyl or acyl
  • R 41 and R 42 which may be the same or different, are hydrogen or optionally substituted alkyl; and when V 1 is CR 9 and V 2 is CR 10 , R 9 and R 4 together with the carbon atoms to which they are attached can form a six membered ring; and when V 1 and V 2 are both N, R 4 can form a sulfur, nitrogen or carbon containing bridge to an ortho carbon atom on Ar; m is 0, 1 or 2; and p is 0 or 1, when Z is Z 1 or Z 2 and is 0 when Z is Z 3 , Z 4 or Z 5 .
  • Ar is preferably a substituted phenyl or pyridyl group. It is generally preferred that it is a 4-trifluoromethyl- phenyl or 5-trifluoromethyl-2-pyridyl, in which the phenyl or pyridyl is optionally further substituted, generally by halogen, especially chloro, nitro diT cyano. Other substituents include trifluoromethoxy, trifluoromethylthio or trifluoromethylsulfonyl.
  • a particularly preferred group of compounds are those where Ar is 2,6-dichloro- 4-trifluoro ethylphenyl, 2-nitro-4-trifluoromethylphenyl, 2-chloro-6-nitro-4-trifluoromethylphenyl or 2-chloro- 6-cyano-4-trifluoromethylphenyl.
  • Alkyl groups are preferably of 1 to 4 carbon atoms and may be substituted by one or more of the same or different groups such as halogen, hydroxy, alkoxy, alkylthio, dihalocyclopropyl, cyano, nitro, optionally substituted amino, optionally substituted imino, acyloxy and aryl.
  • aryl groups are usually phenyl, optionally substituted, e.g. by halogen, alkyl, haloalkyl, alkoxy or nitro.
  • aryl may include heteroaryl groups such as imidazolyl, thienyl, furyl or pyridyl.
  • acyl' includes the residue of sulfonic and phosphorus containing acids as well as carboxylic acids.
  • Acyl groups may be for example alkanoyl, e.g. of 1 to 4 carbon atoms, or alkylsulfonyl or haloalkylsulfonyl.
  • Optionally substituted amino groups are generally of formula NR 16 R 17 .
  • Imino groups may be substituted by groups such as hydroxy or alkoxy.
  • Heterocyclyl groups are generally 4 to 6 membered and can contain various hetero atoms, such as oxygen, nitrogen or sulfur.
  • R 16 and R 17 form a ring this is generally a morpholine or piperidine ring.
  • This ring can be fused to another ring and/or can be substituted, e.g. by one or more optionally substituted alkyl groups.
  • Other rings that R 16 and R 17 can form are optionally substituted 5-membered heteroaryl groups containing 1 to 4 nitrogen atoms, preferably pyrrole.
  • the compounds of the invention have insecticidal and acaricidal activity and are particularly useful in combating a variety of economically important insects, and acarids including animal ectoparasites, e.g. Lepidoptera, including Spodoptera littoralis, Heliothis armi ⁇ era, and Pieris brassicae; Diptera, including Musca domestica, Ceratitis*. ⁇ capitat , Erioischia bra-gsicae, Lucilia- sericata and Aedes aecrvpti; Homoptera, including aphids such as Me ⁇ oura viciae and Nilaparvata lu ⁇ ens; Coleoptera, including Phaedon cochleariae f Anthonomus grandis and corn rootworms fDiabrotica spp., eg.
  • animal ectoparasites e.g. Lepidoptera, including Spodoptera littoralis, Heliothis armi ⁇ era
  • Some compounds also have activity against plant parasitic nematodes, for example root-knot nematodes, such as Meloidocrvne spp. and cyst forming nematodes, such as Heterodera spp..
  • root-knot nematodes such as Meloidocrvne spp.
  • cyst forming nematodes such as Heterodera spp.
  • the compounds of the invention are also active against animal and human endoparasites and especially helminths, ie nematodes, trematodes and cestodes, especially Trichostron ⁇ loidea, e.g. Haemonchus contortus, Trichostroncrylus spp; Dictvocaulus spp; Ascaridoidea. e.g. Toxocara spp; Stron ⁇ ylus spp; and Filarioidea. e.g. Dirofilaria immitis.
  • the invention thus provides a method of combating pests, especially insects, acarids or animal endoparasites, at a locus or host for the pest, infested or liable to be infested therewith, which comprises applying to the locus, host and/or the pest, a"compound of formula I, as defined above.
  • the invention also provides a pesticidal composition which comprises a compound of the invention in admixture with an agriculturally or veterinarily acceptable diluent or carrier.
  • the invention also provides a pharmaceutical composition which comprises a compound of the invention in admixture with a pharmaceutically acceptable diluent or carrier.
  • More than one compound of the invention can, of course, be included in the compositions.
  • compositions can comprise one or more additional pesticides for example compounds known to possess herbicidal, fungicidal, insecticidal, acaricidal or nematicidal properties.
  • additional pesticides for example compounds known to possess herbicidal, fungicidal, insecticidal, acaricidal or nematicidal properties.
  • the compounds of the invention can be used in sequence with the other pesticides.
  • the diluent or carrier in the composition of the invention can be a solid or a liquid optionally in association with a surface-active agent, for example a dispersing agent, emulsifying agent or wetting agent.
  • Suitable surface-active agents include anionic compounds such as a carboxylate, for example a metal carboxylate of a long chain fatty acid; an N-acylsarcosinate; mono- or di-esters of phosphoric acid with fatty alcohol ethoxylates or salts of such esters; fatty alcohol sulfates such as sodium dodecyl sulfate, sodium octadecyl sulfate or sodium cetyl sulfate; ethoxylated fatty alcohol sulfates; ethoxylated alkylphenol sulfates; lignin sulfonates; petroleum sulfonates; alkyl-aryl sulfonates such as alkyl-benzene s
  • butyl-naphthalene sulfonate salts of sulfonated naphthalene-formaldehyde condensates; salts of sulfonated phenol-formaldehyde condensates; or more complex sulfonates such as the amide sulfonates, e.g. the sulfonated condensation product of oleic acid and N-methyl taurine or the dialkyl sulfosuccinates, e.g. the sodium sulfonate of dioctyl succinate.
  • amide sulfonates e.g. the sulfonated condensation product of oleic acid and N-methyl taurine or the dialkyl sulfosuccinates, e.g. the sodium sulfonate of dioctyl succinate.
  • Nonionic agents include condensation products of fatty acid esters, fatty alcohols, fatty acid amides or fatty-alkyl- or alkenyl-substituted phenols with ethylene oxide, fatty esters of polyhydric alcohol ethers, e.g. sorbitan fatty acid esters, condensation products of such esters with ethylene oxide, e.g. polyoxyethylene sorbitan fatty acid esters, block copolymers of ethylene oxide and propylene oxide, acetylenic glycols such as 2,4,7,9-tetramethyl- 5-decyne-4,7-diol, or ethoxylated acetylenic glycols.
  • a cationic surface-active agent examples include, for instance, an aliphatic mono-, di-, or polyamine as an acetate, naphthenate or oleate; an oxygen-containing amine such a amine oxide or polyoxyethylene alkylamine; an amide-linked amine prepared by the condensation of a carboxylic acid with a di- or polyamine; or a quaternary ammonium salt.
  • compositions of the invention can take any form known in the art for the formulation of insecticidal or acaricidal compounds, for example, a solution, a dispersion, an aqueous emulsion, a dusting powder, a seed dressing, a fu igant, a smoke, a dispersible powder, an emulsifiable concentrate, granules or baits; and when being used as an animal or human parasiticide, can be in the form of a preparation, e.g. for oral, parenteral or dermal application, e.g.
  • the composition comprises a compound of the invention dispersed in a liquid medium, preferably water. It is often convenient to supply the consumer with a primary composition which can be diluted with water to form a dispersion having the desired concentration.
  • the primary composition can be provided in any one of the following forms. It can be a dispersible solution which comprises a compound of the invention dissolved in a water-miscible solvent with the addition of a dispersing agent.
  • a further alternative comprises a compound of the invention in the form of a finely ground powder in association with a dispersing agent and intimately mixed with water to give a paste or cream which can if desired be added to an emulsion of oil in water to give a dispersion of active ingredient in an aqueous oil emulsion.
  • An emulsifiable concentrate comprises a compound of the invention dissolved in a water-immiscible solvent together with an emulsifying agent and which is formed into an emulsion on mixing with water.
  • a dusting powder comprises a compound of the invention intimately mixed with a solid pulverulent diluent, for example, kaolin.
  • a granular solid comprises a compound of the invention associated with similar diluents to those which may be employed in dusting powders, but the mixture is granulated by known methods. Alternatively it comprises the active ingredient adsorbed or absorbed on a pre-granular diluent, for example. Fuller's earth, attapulgite or limestone grit.
  • a wettable powder usually comprises the active ingredient in admixture with a suitable surfactant and an inert powder diluent such as china clay.
  • Another suitable concentrate particularly when the product is a solid, is a flowable suspension concentrate which is formed by grinding the compound with water, a wetting agent and a suspending agent.
  • Baits can include an attractant and may comprise a protein hydrolysate e.g. for the control of fruit flies, sugar e.g. for the control of adult Musca spp. or corn cob e.g. for the control of cockroaches.
  • concentration of the active ingredient in the composition of the present invention is preferably within the range of 1 to 30 per cent by weight, especially 5 to 30 per cent by weight.
  • the amount of active ingredient can vary widely and can be, for example, from 5 to 95 per cent by weight of the composition.
  • the compounds of the invention may be prepared by a variety of methods known in the art.
  • Suitable reagents for ring closure include N-chlorosuccinimide and
  • the compound of formula II can be prepared by reacting a compound of formula III
  • Z-R 23 (IV) where R 23 is cyano or an alkoxycarbonyl group can be reduced, e.g. using diisobutylaluminiu hydride in an inert solvent at very low temperature.
  • a compound of formula IV where R 23 is an alkoxycarbonyl group may be reduced by methods known in the art, e.g. using lithium aluminium hydride, diisobutylaluminium hydride or zirconium borohydride (prepared in situ from zirconium tetrachloride and sodium borohydride) in an inert solvent, such as tetrahydrofuran, to give a compound of formula IV, where R 23 is hydroxymethyl.
  • This can be oxidised to give the compound of formula III, e.g. using pyridinium dichromate or manganese dioxide.
  • a compound of formula IV where R 23 is halomethyl may also be reacted with trimethylamine-N-oxide in dimethyl sulfoxide to give a compound of formula III.
  • a compound of formula III can also be prepared by cleavage of the compound of formula IV, where R 23 ia an optionally substituted carbon-carbon double bond, e.g. using ozone.
  • the compound of formula IV where R 23 is hydroxymethyl can also be prepared by reduction of a carboxylic acid of formula IV where R 23 is carboxyl, by known methods.
  • the compound of formula III can also be prepared by formylation, e.g. where Z is Z 2 , by reacting a compound of formula V
  • a compound of formula V may be prepared in known manner by reaction of the diazonium salt of an arylamine, ArNH 2 ⁇ with a compound of formula VI R 5 CH(COMe)-CH 2 COOalkyl (VI)
  • a compound of formula III where Z is Z 2 and R 5 is nitro may be prepared by reaction of an aryl diazonium salt ArN 2 + with diethyl nitrosuccinate in the presence of sodium acetate, followed by cyclisation, for example, with sodium ethoxide. Diethyl nitrosuccinate may be prepared by oxidation of a compound
  • This compound may be prepared by reaction of diethyl succinate with hydroxylamine hydrochloride in the presence of acid or base.
  • a compound of formula IV, where R 23 is alkoxycarbonyl, Z is Z 2 , R 5 is S0 2 C1 and R 6 is amino, may be obtained from the corresponding compound where R 5 is optionally substituted benzylthio, by known methods, e.g. by oxidation with chlorine in acetic acid, with optional protection of the amino group. This compound may then be reacted with a compound HNR 16 R 17 to give a compound where R 5 is S0 2 NR 16 R 17 .
  • R 5 is optionally substituted benzylthio and R 6 is amino
  • R 5 is optionally substituted benzylthio and R 6 is amino
  • R J CN where R 5 is optionally substituted benzylthio and R 24 is optionally substituted alkyl.
  • Ar where R 5 is optionally substituted benzylthio and R 23 is cyano may be similarly prepared by reaction of an arylhydrazine ArNHNH 2 with a compound of formula
  • R 5 where R 5 is optionally substituted benzylthio.
  • a compound of formula VII, in which R 23 is alkoxycarbonyl and R 6 is an N-linked 5-membered heterocycle group containing 1-4 nitrogen atoms may be prepared from a compound of formula VIII by known methods. For example to obtain the compound, where R 6 is pyrrole, the compound of formula VIII can be reacted with 2,5-dimethoxytetrahydro- furan.
  • a compound of formula VII, in which R 6 is halogen, hydrogen, cyano, hydroxy or R 19 S, may be prepared from the compound of formula VIII by known methods, e.g. diazotisation.
  • a compound of formula VII, in which R 6 is hydroxy may subsequently be modified in known manner, e.g. by alkylation with an alkyl halide or dialkyl sulfate.
  • a compound of formula VII, in which R 6 is R 19 S(0) m , where m is 0, may be oxidised in known manner, e.g. using hydrogen peroxide or a per-acid such as m-chloroperbenzoic acid, to give compounds where m is 1 or 2.
  • a compound of formula VIII, in which R 5 is optionally substituted alkoxy may be prepared by reaction of an arylhydrazine, ArNHNH 2 with diethyl cyanomalonate to give a compound of formula VIII, in which R 5 is hydroxy, followed by treatment with an appropriate alkylating agent in the presence of a base.
  • a compound of formula VII, in which R 5 is R 19 S(0) m , where m is 0 and R 19 is optionally substituted alkyl, may be prepared from the corresponding compound where R 5 is SH, e.g. by alkylation with an alkyl halide, ' in the presence of a, base.
  • a compound of formula VII, where R 5 is SH, may be obtained from the corresponding compound where R 5 is optionally substituted benzyl, in known manner.
  • a compound of formula IX may be prepared in known manner from the corresponding compound where R 25 is hydrogen.
  • a compound of formula VII, where R 6 is nitro, may be obtained by nitration of the corresponding compound where R 6 is hydrogen.
  • a compound of formula VII, where R 6 is hydrogen, may be obtained by reaction of a compound of formula IX, where R 25 is halogen, with a compound of formula HCsC-COOR 24 where R 24 is optionally substituted alkyl, in the presence of a base.
  • a compound of formula VIII may be modified by reaction with a suitable alkyl or acyl halide in the presence of a base to give compound of formula VII, where R 6 is NR 16 R 17 .
  • R 3 where R 26 is halogen, preferably chlorine, is reacted a) with a compound of formula XI
  • R 4 -CH CH-R 27 (XI) where R 4 is hydrogen, nitro or optionally substituted alkyl and R 27 is a leaving group, such as alkoxy or substituted amino, e.g. morpholino, to give a compound of formula I, where p is 0, Z is Z 1 , V 1 is CR 9 and V 2 is N, where R 9 is hydrogen and R 4 is hydrogen, nitro or optionally substituted alkyl, or b) with a compound of formula XII
  • R 4 is amino
  • the amino group may be modified in known manner to give other desired values for R 4 .
  • a compound of formula I in which R 3 is H may be further modified in known manner, e.g. by alkylation to give other R 3 groups.
  • the reagent for ring closure and halogenation is preferably the same compound e.g. an N-halosuccinimide.
  • the compound of formula XIII can be obtained by reacting a compound of formula XIV
  • the compound of formula XIV can be obtained by reacting a phenylhydrazine, ArNHNH 2 with glyoxal.
  • a compound of formula IV in which R 23 is cyano, Z is Z 1 , V 1 is CR 9 and V 2 is N, where R 9 is R 19 S(0)m, halogen, nitro, formyl, haloalkyl and R 4 is NH 2 may be prepared from compound of formula XV
  • a compound of formula XV in which R 28 is cyano, R 9 is H and R 4 is NH 2 may be prepared in known manner, e.g. as described in EP 295117.
  • a compound of formula XV where R 28 is alkoxycarbonyl, R 9 is H and R 4 is alkoxy or haloalkoxy may be formed from a compound of formula XV, where R 28 is alkoxycarbonyl, R 9 is H and R 4 is hydroxy, by alkylation in the presence of a base.
  • a compound of formula XV where R 28 is alkoxycarbonyl, R 9 is formyl and R 4 is halogen e.g. chloro may be prepared by reaction of a compound of formula XV where R 28 is alkoxycarbonyl, R 9 is H and R 4 is hydroxy by reaction with dimethylformamide and phosphorous oxychloride.
  • the formyl group may be optionally protected or modified in known manner.
  • a compound of formula XV where R 28 is alkoxycarbonyl, R 9 is hydrogen and R 4 is hydroxy may be prepared in known manner e.g. as described in EP 385 809.
  • R 24 is an ester forming group such as alkyl, e.g. ethyl, using general methods indicated above.
  • the compound of formula XVI can be obtained by ring closing a compound of formula XVII NH,
  • Ar-NH-N C-COOR 24 (XVII) using an appropriate carbony1 compound depending on the desired value of R 4 .
  • R 4 is hydrogen
  • a suitable reagent is an orthoformate ester, e.g. the triethyl ester
  • R 4 is an optionally substituted alkyl or phenyl
  • the corresponding alkanoyl or benzoyl chloride can be used.
  • Compounds of formula XVI, where R 4 is OH can be obtained using phosgene as the ring closing reagent. This group can then be modified in known manner, for example by reaction with phosphorus oxychloride to give a compound where R 4 is chlorine.
  • the compound of formula XVII can be obtained by reacting a compound of formula XVIII with ammonia Br
  • the compound of formula XVI, where R 4 is hydroxy can be obtained by reaction of a compound of formula XVIII with a cyanafe"salt, s c ' as potassium cyariate.
  • the compound of formula XVI, where R 4 is alkylthio can be obtained by reaction of a compound of formula XVI where R 4 is halogen with a compound of formula, R 19 SH in the presence of a base.
  • the alkylthio group can then be oxidised using a suitable oxidising agent, e.g. hydrogen peroxide or m-chloroperbenzoic acid.
  • the compound of formula XVI, where R 4 is nitro can be obtained by nitration of a compound of formula XVI where R 4 is hydrogen.
  • the compound of formula XVI, where R 4 is cyano can be obtained by reaction of a compound of formula XVI where R 4 is trichloromethyl with aqueous ammonia.
  • R 4 is trichloromethyl
  • This group can then in turn be modified in known manner as will be apparent to those skilled in the art.
  • the compound of formula XVIII can be obtained by bro ination of a compound of formula XIX, usually in the presence of an acetate salt
  • Ac Ar-NH-N C-C00R 24 (XIX) where Ac is an alkanoyl group, usually acetyl.
  • the compound of formula XIX can be obtained by diazotisation of a compound
  • the compound of formula XX may be prepared by reaction of a compound of formula XXI (XXI)
  • Ar 1 (which is equivalent to compound XVI) , where Ar 1 and R 29 have the meaning given in formula XXIII can be cyclised in a similar manner and then treated as described for formula XVI.
  • the compound of formula X, where R 26 is amino is novel and forms one aspect of the invention and may be obtained by reacting a compound of formula X, where R 26 is halogen, with ammonia.
  • R 32 is a leaving group, such as halogen, especially fluorine.
  • R 3 may be for example a protecting group, e.g. one of those described in "Protective Groups in Organic Synthesis” by T W Greene, published by John Wiley & Sons.
  • a compound of formula XXV may be prepared by a variety of methods known in the art for synthesis of imidazole rings such as those described in Comprehensive Heterocyclic Chemistry, Volume 5, ed. Katritzky and Rees, Chapter 4.08, pp 457, Pergamon 1984.
  • R 4 or R 10 is NH 2
  • the amino group may be modified in known manner, for example by diazotisation, to give other desired values for R 4 or R 10 , such as halogen, cyano or alkylthio or by reaction with e.g. 2 ,5-dimethoxytetrahydrofuran to give compounds where R 4 or R 10 is pyrrole.
  • a compound of formula III, where Z is Z 1 , V 1 is N and V 2 is CR 10 , in which R 10 is amino, may also be prepared by formylation of a compound of formula XXVI
  • R 4 is hydrogen, optionally substituted alkyl or halogen, e.g. with dimethylformamide and phosphorous oxychloride.
  • a compound_of formula XXVI in which R 4 -is-hydrogen, may be obtained by cyclising a compound of formula XXVII
  • the compound of formula XXVII may be prepared by reacting a compound of formula XXVIII
  • Ar-N CH-OR 35 (XXVIII) in which R 35 is alkyl, with a compound of formula NH 2 CH 2 CN.
  • a compound of formula XXVIII may be prepared by reaction of ArNH 2 With HC(OR 35 ) 3 .
  • a compound of formula XXVI in which R 4 is optionally substituted alkyl or halogen may be prepared from a compound of formula XXVII in which R 34 is cyano and R 33 is optionally substituted alkyl or halogen.
  • a compound of formula XXVII, in which R 34 is cyano and R 33 is optionally substituted alkyl or halogen may be prepared by reacting a compound of formula XXIX
  • a compound of formula XXIX may be- repared-in known manner.
  • Other useful intermediates are compounds of formula XXX
  • a compound of formula III where Z is Z 1 , V 1 is CR 9 and V 2 is CR 10 may also be prepared by formylation of a compound of formula XXXI
  • R 37 is hydrogen, e.g. with dimethylformamide and phosphorous oxychloride.
  • a compound of formula XXXI in which R 37 is hydrogen, cyano, alkoxycarbonyl or an optionally protected formyl group, may be prepared by reaction of a compound of formula XXXII
  • R 37 is hydrogen, cyano, alkoxycarbonyl or a protected formyl group, with a compound of formula Ar-R 32 , where R 32 is a leaving group, such as halogen, especially chlorine or fluorine.
  • a compound of formula XXXII may be prepared by a variety of methods known in the art for synthesis of pyrrole rings such as those described in Comprehensive Heterocyclic Chemistry Volume 4, ed. Katritzky and Rees, Chapter 3.06, pp 313, Pergamon 1984.
  • a compound of formula XXXI in which R 4 and R 10 are optionally substituted alkyl can also be prepared by reaction of a compound of formula XXXIII
  • a compound of formula III in which Z is Z 1 , V 1 is CR 9 and V 2 is CR 10 , where R 9 is cyano, R 4 is hydrogen and R 10 is amino may be prepared by hydrolysing a compound of formula XXXIV NC_ R 38 S j (XXXIV) ⁇
  • R 38 is a bis(alkylthio)methyl or bis(arylthio)- methyl group.
  • a compound of formula XXXIV may be prepared from a compound of formula XXXIV in which R 38 is hydrogen, by reaction with a tris(alkylthio)methane or tris(arylthio)- methane in the presence of a Lewis acid, e.g. dimethyl( ethylthio) sulfonium tetrafluoroborate.
  • a Lewis acid e.g. dimethyl( ethylthio) sulfonium tetrafluoroborate.
  • a ⁇ ompound-of formula XXXIV'in which R 38 is hydrogen, may be prepared by reaction of formylsuccinonitrile or its alkali metal salt with Ar-NH 2 .
  • a compound of formula XXXI in which R 9 is a formyl group, R 4 is an amino group, R 10 is hydrogen and R 37 is a cyano group may be transformed using methods for conversion of formyl groups known to those skilled in the art.
  • the formyl group may be converted to a difluoromethyl group using diethylaminosulfur trifluoride.
  • a compound of formula XXXI in which R 9 is R 19 S, R 4 is amino, R 10 is hydrogen and R 37 is cyano may be prepared by reacting the corresponding compound in which R 9 is hydrogen with a sulfenyl halide of formula R 19 S-Hal (where Hal represents halogen) in the presence of an acid acceptor, e.g. a tertiary amine.
  • a compound of formula XXXI in which R 4 is amino, R 10 is hydrogen and R 37 is cyano may be halogenated to the corresponding compound in which R 10 is halogen or sulfenylated using a sulfenyl halide of formula R 19 S-Hal to the corresponding compound in which R 10 is R 19 S.
  • a compound in which R 9 , R 4 or R 10 represents a group of formula R 19 S0 or R 19 S0 2 may be prepared by oxidising the corresponding compound in which R 9 , R 4 or R 10 represents R 19 S, using, for example a per-acid.
  • Z' is the heterocyclic radical Z, in which the Ar is replaced by H, with a compound Ar-R 32 , where R 32 is a leaving group, such as halogen, e.g. fluorine or chlorine, in the presence of a base.
  • R 3 may be a protecting group such as those described in "Protective Groups in Organic Chemistry” by T W Greene, published by John Wiley and Sons.
  • Other methods for preparing the compound of formula XXXV will be readily apparent those skilled in the art.
  • a compound of formula I where p is 0, Z is Z 5 , Y is NR 12 and R 12 is hydrogen, may be prepared from a compound of formula X, where R 26 is halogen, preferably chlorine, by reaction with a metal thiocyanate, preferably sodium, thiocyanate, in the presence of a base, e.g. triethylamine.
  • R 26 is halogen, preferably chlorine
  • a metal thiocyanate preferably sodium, thiocyanate
  • This compound may be further derivatised, e.g. by alkylation or acylation, to give other values of R 12 .
  • a compound of formula I where p is 0, Z is Z 5 and Y is 0, W 3 is S and W 4 is C, may be prepared by heating a compound of formula XXXVI
  • the compound of formula XXXVI may be prepared by diazotising a compound of formula I where p is 0, Z is Z , Y is NH, W 3 is S and W 4 is C, e.g. by reaction with a nitrite, e.g. sodium nitrite, in acetic acid.
  • a nitrite e.g. sodium nitrite
  • a compound of formula III where Z is Z 5 and ⁇ is O, W 4 is C and W 3 is NR 40 , can be prepared for example by reduction of a compound of formula XXXVII (XXXVII )
  • R 24 is an ester forming group such as alkyl, e.g. ethyl, using general methods indicated above.
  • the compound of formula XXXVII can be obtained by reaction of the compound of XVIII with potassium cyanate, followed by alkylation or by reaction with a substituted isocyanate of formula R ⁇ NCO.
  • R 24 is an ester forming group such as alkyl, e.g. ethyl, R 41 is methyl and R 42 is hydrogen, using general methods indicated above.
  • the compound of formula XXXIX can be obtained by reaction of the compound of formula XIX with triethyl phosphonoacetate and sodium hydride in tetrahydrofuran.
  • a compound of formula III in which p is 0, Z is Z 5 and Y is 0, W 4 is S and W 3 is NH, can be prepared for example by reduction of a compound of formula XXXX (XXXX)
  • R 24 is an ester forming group such as alkyl, e.g. ethyl, using general methods indicated above.
  • the compound of formula XXXX can be obtained by reaction of the compound of XVII with thionyl chloride.
  • the compound of " formula XXXXI may be prepared from a compound of formula IV, where R 23 is cyano by reaction with e.g. gaseous hydrogen chloride in ethanol.
  • the compound of formula IV is known or may be prepared in known manner.
  • a compound of formula I, where R 2 and R 3 are hydrogen, may be obtained by reaction of a compound of formula III, with a compound of formula R l _ C0 -.cHBr 2 and ammonia.
  • R 1 and/or R 2 are hydrogen may be modified by known methods such as e.g. electrophilic substitution reactions to give compounds of formula I where R 1 and/or R 2 are e.g. halogen, nitro etc. These groups may be modified by methods known to those skilled in the art to give other R 1 and R 2 groups. In some cases it may be necessary to have a suitable protecting group at R 3 , which can subsequently be removed, in known manner.
  • R 1 is e.g. trifluoromethyl
  • this may be further reacted with ammonia to give a compound of formula I, where R 1 is cyano.
  • R 1 is e.g. cyano or trifluoromethyl and R 2 is hydrogen
  • the compound may be reacted with a brominating agent, e.g. N-bromosuccinimide, to give a compound of formula I, where R 2 is bromo.
  • a brominating agent e.g. N-bromosuccinimide
  • a compound of formula I in which R 3 is H may be further modified in known manner, e.g. by alkylation to give other R 3 groups.
  • a compound of formula I in which p is 1 may be obtained by reaction of a compound of formula XXXXIII
  • R 39 is a leaving group, such as a halogen, under basic conditions.
  • a compound of formula XXXXIV may be formed from a compound of formula XXXXV
  • the group R 3 is a protecting group, e.g. containing silicon
  • the resulting compound of formula I may be optionally further modified in known manner, e.g. by hydrolysis or reaction with a source of fluoride ion to give compounds of formula I in which R 3 is H.
  • this group can be oxidised using a suitable oxidising agent, e.g. m-chloroperbenzoic acid.
  • a suitable oxidising agent e.g. m-chloroperbenzoic acid.
  • the compounds of formula I in which R 3 is hydrogen may form pesticidally and pharmaceutically acceptable salts with organic or inorganic bases, especially where R 1 and/or R 2 are electron withdrawing groups. These salts also form part of the invention.
  • Pesticidally acceptable salts means salts, the cations of which are known and accepted in the art as being suitable for the formation of salts of pesticidally active acids for use in agriculture or horticulture.
  • pharmaceutically acceptable salts means salts, the cations of which are known and accepted in the art as being suitable for the formation of salts of biologically active acids for use in veterinary or human medicine.
  • the salt is an alkali metal, alkaline earth metal, quaternary ammonium or an amine salt.
  • Amine salts include salts derived from primary, secondary and tertiary amines, including amino sugars, such as N-methylglucamine. Salts may be prepared by reacting the compound of the invention, in known manner, with a suitable base.
  • substituents on the various Z groups in a compound of formula I or its precursors may be modified in known manner to give other desired substituents.
  • compounds containing an alkoxycarbonyl group may be reduced, e.g. with diisobutylaluminium hydride at low temperature to give to give the corresponding carboxaldehyde.
  • they may be reduced by methods known in the art, e.g.
  • Example 1 A solution of 3-[(2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2 ,6-dichloro-4-trifluoromethylphenyl)-2 ,5-dimethyl- pyrrole, (0.53 g) and 2,3-dichloro-5,6-dicyano- 1,4-benzoquinone (0.28 g) in dioxane was heated under reflux for 6 hours. The mixture was poured into water and extracted with ethyl acetate.
  • 2,5-Dimethylpyrrole (2.29 ml) was stirred with sodium hydride (0.54 g of 60% dispersion in oil) for half an hour.
  • l,3-Dichloro-2-fluoro-5-trifluoromethylbenzene (5 g) was added and the mixture heated under reflux for 2 hours.
  • the mixture was poured into water and extracted with ethyl acetate.
  • the extract was washed with water, dried and evaporated and the oil purified by silica gel chromatography to give 1-(2,6-dichloro-4-trifluoro ⁇ methylphenyl)-2 ,5-dimethylpyrrole, as an oil.
  • This compound (5.72 g) was added to a preformed mixture of phosphorus oxychloride (71.6 ml) and dimethylformamide (1.35 ml) . The resulting mixture was then heated under reflux overnight and excess phosphorus oxychloride removed under reduced pressure. Ice was added to the residue and the mixture extracted with dichloro- methane. The extract was worked up to give an oil which was passed through a silica gel column using ether as eluent and the fraction having an R f value of 0.83 was collected, which was shown by nmr to be 5-chloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-ethoxy- carbonyl-4-formyl-lH-pyrazole.
  • Ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxy- lH-pyrazole-3-carboxylate was brominated with N-bromosuccinimide in chloroform to give ethyl 5-bromo- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxy- lH-pyrazole-3-carboxylate, m.p. 139-140°.
  • Lithium borohydride (4.3 g) was added to a solution of this product (35 g) in dry tetrahydrofuran (700 ml) . The mixture was stirred for % hour at room temperature, and then heated under reflux for 2 hours. It was poured into ice/hydrochloric acid and extracted with ethyl acetate. The extract was dried and evaporated and the residue worked up to give 1-(2,6-dichloro-4-trifluoromethyl ⁇ phenyl)-4,5-dihydro-3-hydroxymethyl-5-oxo- lH-l,2,4-triazole, m.p. 231-2°.
  • Ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxy- lH-pyrazole-3-carboxylate was methylated using methyl iodide/sodium hydride in tetrahydrofuran to give ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-methoxy- lH-pyrazole-3-carboxylate, m.p. 148-151°.
  • Chlorodifluoromethane was bubbled through a mixture of ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxy- lH-pyrazole-3-carboxylate (10 g) and aqueous sodium hydroxide (100 ml of 2M) and dioxane (100 ml) . Solvent was evaporated, the residue acidified and the solid collected and dried to give l-(2,6-dichloro-4-trifluoromethyl- phenyl)-4-difluoromethoxy-lH-pyrazole-3-carboxylic acid, m.p. 177-8°.
  • Example 2 l,l-Dibromo-3,3,3-trifluoroacetone (7 g) was added to a solution of sodium acetate trihydrate (7 g) in water (25 ml) and the resulting solution heated on a steam bath for 30 mins. The mixture was cooled to room temperature and added slowly to a solution of l-(2,6-dichloro- 4-trifluoromethylphenyl)-1H-1,2,4-triazole- 3-carboxaldehyde (6.8 g) and aqueous ammonia (30 ml) in methanol (60 ml) . The suspension was stirred for 3 hours, reduced in volume and water added.
  • Example 8 A mixture of vinyl butyl ether (1.13 ml) and triethylamine (1.21 ml) in toluene (2 ml) was added dropwise to a stirred suspension of 2-[ (chloro) (2,6-dichl ro- ... , 4-trifluoromethylphenylhydrazono)methyl]-4 ,5-dicyano- 1H-imidazole (1.75 g) in toluene (3 ml) at 90°. The mixture was heated at this temperature for 3 hours, cooled and filtered. 2N Hydrochloric acid was added and the mixture extracted with ethyl acetate.
  • Example 11 A mixture of compound 10a (2.01 g) and thionyl chloride (40 ml) was heated under reflux for 2 hours. Excess thionyl chloride was evaporated and the residue dissolved in tetrahydrofuran (20 ml) and added to aqueous ammonia (40 ml) . The mixture was stirred at room temperature for 15 minutes and water (200 ml) was added.
  • Example 15 Compound lg was reduced with lithium borohydride in a manner similar to that described in the preparation of the starting material for compound is, to give 5-chloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano- lH-imidazol-2-yl)-3-hydroxymethyl-lH-pyrazole, m.p. 186-8°. (Compound 15a) .
  • Trifluoroacetic anhydride (0.08 g) was added to a solution of Compound 17a (0.16 g) and pyridine (0.11 g) in dioxane (5 ml) . with ice-cooling. The mixture was stirred at room temperature overnight, and then heated under reflux for 4 hours. It was diluted with 2M hydrochloric acid, extracted with ether and the extract worked up to give 5-chloro- 3-cyano-l-(2,6-dichloro-4-trifluoromethylphenyl)- 4-(4,5-dicyano-lH-imidazol-2-yl)-lH-pyrazole, m.p. 119-123°. (Compound 18a).
  • Triethylamine (1.4 g) was added dropwise to a stirred mixture of 2-[ (chloro) (2,6-dichloro-4-trifluoromethyl- phenylhydrazono)methyl]-4,5-dicyano-lH-imidazole (5.5 g) , fumaronitrile (2.1 g) , chloroform (100 ml) and silver acetate (2.5 g) .
  • the mixture was heated under reflux 5 hours and then subjected to flash column chromatography to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-cyano- 3-(4,5-dicyano-lH-imidazol-2-yl)-lH-pyrazole, m.p. 308-9° (Compound 21a) .
  • Example 22 tert-Butyl nitrite (3 ml) was added dropwise to a mixture of compound 7c (3 g) and copper (II) chloride (2 g) in acetonitrile (100 ml) . The mixture was stirred overnight at room temperature, poured into dilute hydrochloric acid and extracted with ethyl acetate. The extract was dried and evaporated and the residue worked up to give 5-chloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-cyano- 3-(4,5-dicyano-lH " -imidazol-2-yl)-lH-pyrazole, m.p. >300° (dec) (Compound 22a).
  • Compounds are assessed for activity against one or more of the following:
  • Lucilia sericata (sheep blow fly) a) contact test (LS) b) systemic test (LSS) Boophilus icroplus (blue tick) a) injection test (BMI) Musca domestica (house fly) a) contact test (MD)
  • Blattella germanica cockroach
  • BG contact test
  • BGB bait test
  • Helminths a) Trichostrongylus colubriformis (TC) b) Heligmosomoides polygyrus (HP)
  • test compound 100 mg are dissolved in 0.2 ml dimethyl sulfoxide and diluted with corn oil to the desired concentration. Approx 0.25 ml doses are fed to male mice, using 5 mice for each dose. 4 hours after treatment the mice are killed with carbon dioxide and the upper parts of hind legs removed and skinned. These are placed individually into sample tubes which are infested with first instar larvae of sheep blow fly (Lucilia sericata) , closed by a cotton wool plug and held at 25° for 24 hours. The activity is then assessed in comparison to controls. Compounds are considered active if the LC 50 is less than 100 mg/kg of mouse.
  • Test compounds are dissolved in a suitable solvent to a desired concentration.
  • a microapplicator 2 microlitres of the solution are injected into the blood filled stomach of a tick (Boophilus microplus.. 5 replicate ticks are treated at each concentration and subsequently each tick is retained separately in partitioned petri dish held at 25°C and >80% R.H. , until mortality of ticks or fecundity and viability of eggs produced by survivors can be assessed.
  • the percentage reduction in total reproductive capacity i.e. the combined effects of adult mortality, reduced fecundity and mortality of eggs is then recorded and compared with controls.
  • Compounds are considered active if they result in at least 50% reduction of reproductive capacity at a concentration of 20 microgram/tick or less.
  • Trichostrongylus colubriformis adults worms of the parasitic nematode Trichostrongylus colubriformis are cultured in multi-well plates containing sterile culture medium and test compound at a concentration of 100 ppm. The cultures are maintained in a sterile carbon dioxide incubator at 37°, at a constant air/carbon dioxide ratio of 95:5 (v/v). After 5 days the mortality is assessed in comparison with controls. Compounds are considered active if the LC 50 is less than 100 ppm.
  • mice Groups of five mice are infected orally with 100 infective stage larvae (L3) of the murine gastrointestinal nematode Heligmosomoides polygyrus. After six days the mice are orally dosed with 50 ⁇ l of the test compound at the desired concentration in a carrier solution containing 1% wetter and 0.05% ethyl cellulose. A control group receives carrier only. After 7 days the mice are killed and the small intestine examined for worm count. Compounds are considered active if they give >50% worm reduction compared with the controls at a rate of 100 mg/kg mouse body weight.

Abstract

Compounds of formula (I) useful in combating pests, especially insects, acarids or animal endoparasites.

Description

Title; Imidazole pesticides
Field of the invention
This invention relates to new imidazoles having pesticidal and especially insecticidal, acaricidal and animal endoparasiticidal activity.
Prior Art
In our EP 412 849, we have disclosed that certain aryl-
1,2,3-triazoles and arylpyrazoles in which an imidazol(in)e group is attached directly or indirectly through its 2-position to the triazole or pyrazole ring, have pesticidal activity. We have now found that other compounds comprising an imidazole, substituted in the 2-position, directly or indirectly by aryl-substituted azolyl groups have good pesticidal activity. The bulk of the compounds have a priority date earlier than the publication date of EP 412 849. The^prior art disclosed..in that application is incorporated by reference.
Description of the Invention The present invention provides compounds of formula I
Figure imgf000003_0001
RJ where Z is a nitrogen containing heterocycle of formula Z1, Z2, Z3, Z4 or Z5
Figure imgf000004_0001
(Z1) (Z2)
Figure imgf000004_0002
(Z3) (Z4)
Figure imgf000004_0003
(Z5) and salts thereof, in which Ar is aryl; V1 is N or CR9; V2 is N or CR10; w1 is N or CR8;
W2 is N or CR11; except W1 and W2 are not both N; W3 is O, S, NR40 or -CR41=CR42-; X is O or S;
Y is O, S or N 12. w4 is C or can also be S when Y is 0; A is S(0)m, 0 or NR13;
R1 and R2 are hydrogen, optionally substituted alkyl, cyano, halogen or nitro; R3 is hydrogen, optionally substituted alkyl, acyl, optionally substituted alkoxycarbonyl or sulfamoyl; R5 is hydrogen, halogen, optionally substituted alkyl, optionally substituted alkoxy, -NR16R17, cyano, nitro, S02NR16R17, CYNR16R17, COOR18 or R19S(0)m;
R4 and R10, which may be the same or different, are hydrogen, halogen, hydroxy, mercapto, cyano, nitro, optionally substituted alkyl, optionally substituted alkoxy, -NR16R17, -S02NR16R17, CHO, CH2OH, COOR18 or
R19S(0)m;
R _6° is substituted alkyl, hydroxy, alkoxy, haloalkoxy, cyano, nitro, R19S(0)m or an N-linked 5-membered heteroaryl group containing 1-4 nitrogen atoms; and when R5 is cyano, -CYNR16R17, -COOR18, optionally substituted alkoxy, nitro, -NR16R17 or _S02NR16R17, R6. can also be hydrogen, halogen, alkyl or -NR16R17; R7, R8 and R11, which may be the same or different, are hydrogen, halogen, optionally substituted alkyl or optionally substituted alkylthio;
R9 is hydrogen, halogen, optionally substituted alkyl, for yl, optionally substitutjed_alkoxyr aryl., cyano, nitro, hydroxy, trialkylsilyloxy, CYNR16R17, COOR18 or R19S(0)m;
R12 is hydrogen, optionally substituted alkyl or acyl;
R13 is hydrogen, alkyl or acyl;
R16 and R17 are the same or different and are hydrogen, optionally substituted alkyl, acyl or aryl, or together with the nitrogen to which they are attached, form a 5 to 7 membered ring which can contain other hetero atoms;
R18 is hydrogen or optionally substituted alkyl; R19 is optionally substituted alkyl;
R40 is hydrogen, optionally substituted alkyl or acyl;
R41 and R42, which may be the same or different, are hydrogen or optionally substituted alkyl; and when V1 is CR9 and V2 is CR10, R9 and R4 together with the carbon atoms to which they are attached can form a six membered ring; and when V1 and V2 are both N, R4 can form a sulfur, nitrogen or carbon containing bridge to an ortho carbon atom on Ar; m is 0, 1 or 2; and p is 0 or 1, when Z is Z1 or Z2and is 0 when Z is Z3, Z4 or Z5.
Ar is preferably a substituted phenyl or pyridyl group. It is generally preferred that it is a 4-trifluoromethyl- phenyl or 5-trifluoromethyl-2-pyridyl, in which the phenyl or pyridyl is optionally further substituted, generally by halogen, especially chloro, nitro diT cyano. Other substituents include trifluoromethoxy, trifluoromethylthio or trifluoromethylsulfonyl. A particularly preferred group of compounds are those where Ar is 2,6-dichloro- 4-trifluoro ethylphenyl, 2-nitro-4-trifluoromethylphenyl, 2-chloro-6-nitro-4-trifluoromethylphenyl or 2-chloro- 6-cyano-4-trifluoromethylphenyl. -
Alkyl groups are preferably of 1 to 4 carbon atoms and may be substituted by one or more of the same or different groups such as halogen, hydroxy, alkoxy, alkylthio, dihalocyclopropyl, cyano, nitro, optionally substituted amino, optionally substituted imino, acyloxy and aryl. Apart from Ar, aryl groups are usually phenyl, optionally substituted, e.g. by halogen, alkyl, haloalkyl, alkoxy or nitro. The term aryl may include heteroaryl groups such as imidazolyl, thienyl, furyl or pyridyl. The term 'acyl' includes the residue of sulfonic and phosphorus containing acids as well as carboxylic acids. Acyl groups may be for example alkanoyl, e.g. of 1 to 4 carbon atoms, or alkylsulfonyl or haloalkylsulfonyl. Optionally substituted amino groups are generally of formula NR16R17. Imino groups may be substituted by groups such as hydroxy or alkoxy. Heterocyclyl groups are generally 4 to 6 membered and can contain various hetero atoms, such as oxygen, nitrogen or sulfur.
When R16 and R17 form a ring this is generally a morpholine or piperidine ring. This ring can be fused to another ring and/or can be substituted, e.g. by one or more optionally substituted alkyl groups. Other rings that R16 and R17 can form are optionally substituted 5-membered heteroaryl groups containing 1 to 4 nitrogen atoms, preferably pyrrole.
The compounds of the invention have insecticidal and acaricidal activity and are particularly useful in combating a variety of economically important insects, and acarids including animal ectoparasites, e.g. Lepidoptera, including Spodoptera littoralis, Heliothis armiαera, and Pieris brassicae; Diptera, including Musca domestica, Ceratitis*.^capitat , Erioischia bra-gsicae, Lucilia- sericata and Aedes aecrvpti; Homoptera, including aphids such as Meσoura viciae and Nilaparvata luσens; Coleoptera, including Phaedon cochleariaef Anthonomus grandis and corn rootworms fDiabrotica spp., eg. Diabrotica undecimpunctata. ; Orthoptera, including Blattella σermanica; ticks, e.g. Booohilus microplus and lice, including Damalinia bovis and Linoσnathus vituli.
Some compounds also have activity against plant parasitic nematodes, for example root-knot nematodes, such as Meloidocrvne spp. and cyst forming nematodes, such as Heterodera spp..
The compounds of the invention are also active against animal and human endoparasites and especially helminths, ie nematodes, trematodes and cestodes, especially Trichostronσγloidea, e.g. Haemonchus contortus, Trichostroncrylus spp; Dictvocaulus spp; Ascaridoidea. e.g. Toxocara spp; Stronσylus spp; and Filarioidea. e.g. Dirofilaria immitis. Onchocerca spp: Trematoda. including Fasciola hepatica and Schistosoma spp. ; and Cestoda. including Taenia spp and Moniezia spp., and protozoan parasites, e.g. Plasmodiu spp.; Trvpanosoma spp. and Ei eria spp.
The invention thus provides a method of combating pests, especially insects, acarids or animal endoparasites, at a locus or host for the pest, infested or liable to be infested therewith, which comprises applying to the locus, host and/or the pest, a"compound of formula I, as defined above.
Some novel compounds of formula I have weak pesticidal activity but still have utility as intermediates and such compounds also form one aspect of the invention.
The invention also provides a pesticidal composition which comprises a compound of the invention in admixture with an agriculturally or veterinarily acceptable diluent or carrier.
The invention also provides a pharmaceutical composition which comprises a compound of the invention in admixture with a pharmaceutically acceptable diluent or carrier.
More than one compound of the invention can, of course, be included in the compositions.
In addition the compositions can comprise one or more additional pesticides for example compounds known to possess herbicidal, fungicidal, insecticidal, acaricidal or nematicidal properties. Alternatively the compounds of the invention can be used in sequence with the other pesticides.
The diluent or carrier in the composition of the invention can be a solid or a liquid optionally in association with a surface-active agent, for example a dispersing agent, emulsifying agent or wetting agent. Suitable surface-active agents include anionic compounds such as a carboxylate, for example a metal carboxylate of a long chain fatty acid; an N-acylsarcosinate; mono- or di-esters of phosphoric acid with fatty alcohol ethoxylates or salts of such esters; fatty alcohol sulfates such as sodium dodecyl sulfate, sodium octadecyl sulfate or sodium cetyl sulfate; ethoxylated fatty alcohol sulfates; ethoxylated alkylphenol sulfates; lignin sulfonates; petroleum sulfonates; alkyl-aryl sulfonates such as alkyl-benzene sulfonates or lower alkylnaphthalene sulfonates, e.g. butyl-naphthalene sulfonate; salts of sulfonated naphthalene-formaldehyde condensates; salts of sulfonated phenol-formaldehyde condensates; or more complex sulfonates such as the amide sulfonates, e.g. the sulfonated condensation product of oleic acid and N-methyl taurine or the dialkyl sulfosuccinates, e.g. the sodium sulfonate of dioctyl succinate. Nonionic agents include condensation products of fatty acid esters, fatty alcohols, fatty acid amides or fatty-alkyl- or alkenyl-substituted phenols with ethylene oxide, fatty esters of polyhydric alcohol ethers, e.g. sorbitan fatty acid esters, condensation products of such esters with ethylene oxide, e.g. polyoxyethylene sorbitan fatty acid esters, block copolymers of ethylene oxide and propylene oxide, acetylenic glycols such as 2,4,7,9-tetramethyl- 5-decyne-4,7-diol, or ethoxylated acetylenic glycols. Examples of a cationic surface-active agent include, for instance, an aliphatic mono-, di-, or polyamine as an acetate, naphthenate or oleate; an oxygen-containing amine such a amine oxide or polyoxyethylene alkylamine; an amide-linked amine prepared by the condensation of a carboxylic acid with a di- or polyamine; or a quaternary ammonium salt.
The compositions of the invention can take any form known in the art for the formulation of insecticidal or acaricidal compounds, for example, a solution, a dispersion, an aqueous emulsion, a dusting powder, a seed dressing, a fu igant, a smoke, a dispersible powder, an emulsifiable concentrate, granules or baits; and when being used as an animal or human parasiticide, can be in the form of a preparation, e.g. for oral, parenteral or dermal application, e.g. in the form of powders, solutions, suspensions, tablets, capsules, drenches, boluses, pour-ons-, dips, sprays, injectables or as food additives. Moreover it can be in a suitable form for direct application or as a concentrate or primary composition which requires dilution with a suitable quantity of water or other diluent before application.
As a dispersion, the composition comprises a compound of the invention dispersed in a liquid medium, preferably water. It is often convenient to supply the consumer with a primary composition which can be diluted with water to form a dispersion having the desired concentration. The primary composition can be provided in any one of the following forms. It can be a dispersible solution which comprises a compound of the invention dissolved in a water-miscible solvent with the addition of a dispersing agent. A further alternative comprises a compound of the invention in the form of a finely ground powder in association with a dispersing agent and intimately mixed with water to give a paste or cream which can if desired be added to an emulsion of oil in water to give a dispersion of active ingredient in an aqueous oil emulsion.
An emulsifiable concentrate comprises a compound of the invention dissolved in a water-immiscible solvent together with an emulsifying agent and which is formed into an emulsion on mixing with water.
A dusting powder comprises a compound of the invention intimately mixed with a solid pulverulent diluent, for example, kaolin.
A granular solid comprises a compound of the invention associated with similar diluents to those which may be employed in dusting powders, but the mixture is granulated by known methods. Alternatively it comprises the active ingredient adsorbed or absorbed on a pre-granular diluent, for example. Fuller's earth, attapulgite or limestone grit.
A wettable powder usually comprises the active ingredient in admixture with a suitable surfactant and an inert powder diluent such as china clay.
Another suitable concentrate, particularly when the product is a solid, is a flowable suspension concentrate which is formed by grinding the compound with water, a wetting agent and a suspending agent.
Baits can include an attractant and may comprise a protein hydrolysate e.g. for the control of fruit flies, sugar e.g. for the control of adult Musca spp. or corn cob e.g. for the control of cockroaches. The concentration of the active ingredient in the composition of the present invention is preferably within the range of 1 to 30 per cent by weight, especially 5 to 30 per cent by weight. In a primary composition the amount of active ingredient can vary widely and can be, for example, from 5 to 95 per cent by weight of the composition.
The compounds of the invention may be prepared by a variety of methods known in the art.
For example: compounds where p is 0, can be obtained by a process in which a compound of formula II
Z-CH=N-CR1=CR2-NH2 (II) is ring closed to give a compound of formula I, where R3 is hydrogen, and optionally modifying this in known manner to give compounds where R3 is other than hydrogen. Suitable reagents for ring closure include N-chlorosuccinimide and
2,3-dichloro-5,6-dicyano-l,4-benzoquinone.
The compound of formula II can be prepared by reacting a compound of formula III
Z-CHO (III) with a compound of formula H2N-CR1=CR2-NH2
The compounds of formula III are known or can be prepared by known means. The preparation will depend on the nature of the Z heterocycle. Thus a compound of formula IV
Z-R23 (IV) where R23 is cyano or an alkoxycarbonyl group, can be reduced, e.g. using diisobutylaluminiu hydride in an inert solvent at very low temperature. Alternatively a compound of formula IV where R23 is an alkoxycarbonyl group, may be reduced by methods known in the art, e.g. using lithium aluminium hydride, diisobutylaluminium hydride or zirconium borohydride (prepared in situ from zirconium tetrachloride and sodium borohydride) in an inert solvent, such as tetrahydrofuran, to give a compound of formula IV, where R23 is hydroxymethyl. This can be oxidised to give the compound of formula III, e.g. using pyridinium dichromate or manganese dioxide.
A compound of formula IV where R23 is halomethyl, may also be reacted with trimethylamine-N-oxide in dimethyl sulfoxide to give a compound of formula III.
A compound of formula III can also be prepared by cleavage of the compound of formula IV, where R23 ia an optionally substituted carbon-carbon double bond, e.g. using ozone.
The compound of formula IV where R23 is hydroxymethyl, can also be prepared by reduction of a carboxylic acid of formula IV where R23 is carboxyl, by known methods.
The compound of formula III can also be prepared by formylation, e.g. where Z is Z2, by reacting a compound of formula V
Figure imgf000013_0001
N
I
Ar with dimethylformamide in the presence of phosphorus oxychloride or phosphorus oxybromide to give respectively the compounds where R6 is chlorine or bromine.
A compound of formula V, may be prepared in known manner by reaction of the diazonium salt of an arylamine, ArNH2^ with a compound of formula VI R5CH(COMe)-CH2COOalkyl (VI)
A compound of formula III where Z is Z2 and R5 is nitro may be prepared by reaction of an aryl diazonium salt ArN2+ with diethyl nitrosuccinate in the presence of sodium acetate, followed by cyclisation, for example, with sodium ethoxide. Diethyl nitrosuccinate may be prepared by oxidation of a compound
EtOOC-C(=NOH)-CH2COOEt with a suitable oxidising agent. This compound may be prepared by reaction of diethyl succinate with hydroxylamine hydrochloride in the presence of acid or base.
A compound of formula IV, where R23 is alkoxycarbonyl, Z is Z2, R5 is S02C1 and R6 is amino, may be obtained from the corresponding compound where R5 is optionally substituted benzylthio, by known methods, e.g. by oxidation with chlorine in acetic acid, with optional protection of the amino group. This compound may then be reacted with a compound HNR16R17 to give a compound where R5 is S02NR16R17.
The required intermediate of formula VII
(VII)
Figure imgf000014_0001
where R5 is optionally substituted benzylthio and R6 is amino, may be prepared by reaction of an arylhydrazine
ArNHNH2 with a compound of formula R5 COOR24
/
C=C
N
RJ CN where R5 is optionally substituted benzylthio and R24 is optionally substituted alkyl.
An intermediate of formula VIII
Figure imgf000015_0001
Ar where R5 is optionally substituted benzylthio and R23 is cyano, may be similarly prepared by reaction of an arylhydrazine ArNHNH2 with a compound of formula
R5 £N c=c
R5 CN where R5 is optionally substituted benzylthio.
Other intermediates of formula VIII, in which R23 is alkoxycarbonyl, may be similarly prepared by reaction of an arylhydrazine
ArNHNH2 with a compound of formula
R5 .COOR24
/ \ alkoxy CN
A compound of formula VII, in which R23 is alkoxycarbonyl and R6 is an N-linked 5-membered heterocycle group containing 1-4 nitrogen atoms may be prepared from a compound of formula VIII by known methods. For example to obtain the compound, where R6 is pyrrole, the compound of formula VIII can be reacted with 2,5-dimethoxytetrahydro- furan.
A compound of formula VII, in which R6 is halogen, hydrogen, cyano, hydroxy or R19S, may be prepared from the compound of formula VIII by known methods, e.g. diazotisation.
A compound of formula VII, in which R6 is hydroxy may subsequently be modified in known manner, e.g. by alkylation with an alkyl halide or dialkyl sulfate.
A compound of formula VII, in which R6 is R19S(0)m, where m is 0, may be oxidised in known manner, e.g. using hydrogen peroxide or a per-acid such as m-chloroperbenzoic acid, to give compounds where m is 1 or 2.
A compound of formula VIII, in which R5 is optionally substituted alkoxy, may be prepared by reaction of an arylhydrazine, ArNHNH2 with diethyl cyanomalonate to give a compound of formula VIII, in which R5 is hydroxy, followed by treatment with an appropriate alkylating agent in the presence of a base.
A compound of formula VII, in which R5 is R19S(0)m, where m is 0 and R19 is optionally substituted alkyl, may be prepared from the corresponding compound where R5 is SH, e.g. by alkylation with an alkyl halide,' in the presence of a, base.
A compound of formula VII, where R5 is SH, may be obtained from the corresponding compound where R5 is optionally substituted benzyl, in known manner.
A compound of formula VII, where R6 is haloalkyl and R23 is alkoxycarbonyl, may be obtained by reacting a compound of formula IX Ar-NH-N=CH(R5)-R25 (IX) where R25 is halogen, e.g. chlorine or bromine, with a compound R6COCH2COOR24, where R24 is optionally substituted alkyl.
A compound of formula IX may be prepared in known manner from the corresponding compound where R25 is hydrogen.
A compound of formula VII, where R6 is nitro, may be obtained by nitration of the corresponding compound where R6 is hydrogen.
A compound of formula VII, where R6 is hydrogen, may be obtained by reaction of a compound of formula IX, where R25 is halogen, with a compound of formula HCsC-COOR24 where R24 is optionally substituted alkyl, in the presence of a base.
A compound of formula VIII, may be modified by reaction with a suitable alkyl or acyl halide in the presence of a base to give compound of formula VII, where R6 is NR16R17.
Compounds of formula I, where p is 0, Z is Z1, V1 is CR9 and V2 is N, can be obtained by a variety of known methods. For example, a compound of formula X
Figure imgf000018_0001
R3 where R26 is halogen, preferably chlorine, is reacted a) with a compound of formula XI
R4-CH=CH-R27 (XI) where R4 is hydrogen, nitro or optionally substituted alkyl and R27 is a leaving group, such as alkoxy or substituted amino, e.g. morpholino, to give a compound of formula I, where p is 0, Z is Z1, V1 is CR9 and V2 is N, where R9is hydrogen and R4 is hydrogen, nitro or optionally substituted alkyl, or b) with a compound of formula XII
R9-CH2-CN (XII) where R9 is cyano, nitro, COOR18, R19SO or R19S02, to give a compound of formula I, where R4 is amino.
When compounds are obtained where R4 is amino, the amino group may be modified in known manner to give other desired values for R4.
When compounds are obtained where R9 is COOR18 this can also be modified in known manner to give compounds where R: 9 is another group.
A compound of formula I in which R3 is H may be further modified in known manner, e.g. by alkylation to give other R3 groups.
The compound of formula X is novel and forms one aspect of the invention. It can be obtained by ring closure of a compound of formula XIII Ar-NH-N=CH-CH=N-CR1=CR2-NH2 (XIII) in the presence of a halogenating agent. The reagent for ring closure and halogenation is preferably the same compound e.g. an N-halosuccinimide.
The compound of formula XIII can be obtained by reacting a compound of formula XIV
Ar-NH-N=CH-CHO (XIV)
• with a compound of formula H2N-CR1=CR2-NH2
The compound of formula XIV can be obtained by reacting a phenylhydrazine, ArNHNH2 with glyoxal.
A compound of formula IV, in which R23 is cyano, Z is Z1, V1 is CR9 and V2 is N, where R9 is R19S(0)m, halogen, nitro, formyl, haloalkyl and R4 is NH2 may be prepared from compound of formula XV
Figure imgf000019_0001
Ar in which R28 is cyano, R9 is H and R4 is NH2, in known manner with optional protection of the amino group e.g. by halogenation, nitration etc. Groups such as formyl may be optionally protected or further modified.
A compound of formula XV in which R28 is cyano, R9 is H and R4 is NH2, may be prepared in known manner, e.g. as described in EP 295117.
In a compound of formula XV, in which R4 is NH2 the amino group may be optionally protected or modified in known manner to give other values for R4.
A compound of formula XV where R28 is alkoxycarbonyl, R9 is H and R4 is alkoxy or haloalkoxy may be formed from a compound of formula XV, where R28 is alkoxycarbonyl, R9 is H and R4 is hydroxy, by alkylation in the presence of a base.
A compound of formula XV where R28 is alkoxycarbonyl, R9 is formyl and R4 is halogen e.g. chloro, may be prepared by reaction of a compound of formula XV where R28 is alkoxycarbonyl, R9 is H and R4 is hydroxy by reaction with dimethylformamide and phosphorous oxychloride.
The formyl group may be optionally protected or modified in known manner.
A compound of formula XV where R28 is alkoxycarbonyl, R9 is hydrogen and R4 is hydroxy may be prepared in known manner e.g. as described in EP 385 809.
A compound of formula III, in which Z is Z1 and V1 = v2 = N, can be prepared for example by reduction of a compound of formula XVI
N π— COOR24
II N (XVI)
R4 N
I
Ar where R24 is an ester forming group such as alkyl, e.g. ethyl, using general methods indicated above.
The compound of formula XVI can be obtained by ring closing a compound of formula XVII NH,
Ar-NH-N=C-COOR24 (XVII) using an appropriate carbony1 compound depending on the desired value of R4. For example, when R4 is hydrogen a suitable reagent is an orthoformate ester, e.g. the triethyl ester; when R4 is an optionally substituted alkyl or phenyl, the corresponding alkanoyl or benzoyl chloride can be used. Compounds of formula XVI, where R4 is OH can be obtained using phosgene as the ring closing reagent. This group can then be modified in known manner, for example by reaction with phosphorus oxychloride to give a compound where R4 is chlorine.
The compound of formula XVII can be obtained by reacting a compound of formula XVIII with ammonia Br
Ar-NH-N=C-COOR24 (XVIII)
The compound of formula XVI, where R4 is hydroxy can be obtained by reaction of a compound of formula XVIII with a cyanafe"salt, s c ' as potassium cyariate.
The compound of formula XVI, where R4 is alkylthio can be obtained by reaction of a compound of formula XVI where R4 is halogen with a compound of formula, R19SH in the presence of a base. The alkylthio group can then be oxidised using a suitable oxidising agent, e.g. hydrogen peroxide or m-chloroperbenzoic acid.
The compound of formula XVI, where R4 is nitro can be obtained by nitration of a compound of formula XVI where R4 is hydrogen.
The compound of formula XVI, where R4 is cyano can be obtained by reaction of a compound of formula XVI where R4 is trichloromethyl with aqueous ammonia.
Compounds where R4 is trichloromethyl can be further modified, e.g. by reaction with sodium hydroxide to give compounds where R4 is carboxy. This group can then in turn be modified in known manner as will be apparent to those skilled in the art.
The compound of formula XVIII can be obtained by bro ination of a compound of formula XIX, usually in the presence of an acetate salt
Ac Ar-NH-N=C-C00R24 (XIX) where Ac is an alkanoyl group, usually acetyl.
The compound of formula XIX can be obtained by diazotisation of a compound
ArNH2 followed by reaction with a compound
AcCH2C00R24
A compound of formula III, where Z is Z1 and V1 = V2 = N and R4 is a sulfur bridge to an ortho carbon atom of Ar, can be formed by deprotection in known manner of a compound of formula XX
N [j— CH(0Me)2
|l N (XX) s
N
I
Ar
The compound of formula XX may be prepared by reaction of a compound of formula XXI (XXI)
Figure imgf000023_0003
M where R29 is halogen or methylsulfonyl and M is a metal, with a compound of formula XXII
R30-Ar-R31 (XXII) where R30 is a leaving group in the position on the Ar where Ar is attached to the triazole ring in formula XX
*ϊi , t -yr\ and RJ1 is halogen or nitro and is in position ortho to R , to give a compound of formula XXIII
(XXIII)
Figure imgf000023_0001
where Ar1 is Ar substituted by R31 in the ortho position, and cyclising this compound to the desired compound of formula XX, in the presence of sodium sulfide.
A compound of formula XXIV
Figure imgf000023_0002
Ar1 (which is equivalent to compound XVI) , where Ar1 and R29 have the meaning given in formula XXIII can be cyclised in a similar manner and then treated as described for formula XVI.
The compound of formula I, where p is 0, Z is Z1 and V1 = V2 = N, may also be prepared by ring closure of a compound of formula X, where R26 is amino, using an appropriate carbonyl compound depending on the desired value of R4, as described for ring closure of compound XVII .
The compound of formula X, where R26 is amino, is novel and forms one aspect of the invention and may be obtained by reacting a compound of formula X, where R26 is halogen, with ammonia.
A compound of formula IV, where Z is Z1, V1 is N and V2 is CR10, and R23 is for example cyano, alkoxycarbonyl or a group T, where T is
Figure imgf000024_0001
I
may be prepared by reaction of a compound of formula XXV
Figure imgf000024_0002
H with a compound of formula ArR32, where R32 is a leaving group, such as halogen, especially fluorine.
Where R23 = T, R3 may be for example a protecting group, e.g. one of those described in "Protective Groups in Organic Synthesis" by T W Greene, published by John Wiley & Sons.
A compound of formula XXV may be prepared by a variety of methods known in the art for synthesis of imidazole rings such as those described in Comprehensive Heterocyclic Chemistry, Volume 5, ed. Katritzky and Rees, Chapter 4.08, pp 457, Pergamon 1984. When compounds are obtained where R4 or R10 is NH2, the amino group may be modified in known manner, for example by diazotisation, to give other desired values for R4 or R10, such as halogen, cyano or alkylthio or by reaction with e.g. 2 ,5-dimethoxytetrahydrofuran to give compounds where R4 or R10 is pyrrole.
A compound of formula III, where Z is Z1, V1 is N and V2 is CR10, in which R10 is amino, may also be prepared by formylation of a compound of formula XXVI
Figure imgf000025_0001
I Ar in which R4 is hydrogen, optionally substituted alkyl or halogen, e.g. with dimethylformamide and phosphorous oxychloride.
A compound_of formula XXVI in which R4 -is-hydrogen, may be obtained by cyclising a compound of formula XXVII
Ar-N=C-NHCH2-R34 (XXVII)
R33 in which R33 is hydrogen and R34 is cyano, in the presence of a base.
The compound of formula XXVII may be prepared by reacting a compound of formula XXVIII
Ar-N=CH-OR35 (XXVIII) in which R35 is alkyl, with a compound of formula NH2CH2CN.
A compound of formula XXVIII may be prepared by reaction of ArNH2 With HC(OR35)3. A compound of formula XXVI in which R4 is optionally substituted alkyl or halogen may be prepared from a compound of formula XXVII in which R34 is cyano and R33 is optionally substituted alkyl or halogen.
A compound of formula XXVII, in which R34 is cyano and R33 is optionally substituted alkyl or halogen may be prepared by reacting a compound of formula XXIX
Ar-N=C-R36 (XXIX)
R33 in which R33 is optionally substituted alkyl or halogen and R36 is halogen, with a compound of formula NH2CH2CN.
A compound of formula XXIX may be- repared-in known manner. Other useful intermediates are compounds of formula XXX
Figure imgf000026_0001
I Ar in which R33 is as defined above. These may be prepared from a compound of formula XXVII in which R34is alkoxycarbonyl. This latter compound may be prepared by reaction of a compound of formula XXIX with NH2CH2R34.
Compounds of formula XXX may be further transformed, e.g. by a reaction with dimethylformamide and phosphorous oxychloride to give compounds of formula III where Z is Z1, V1 is N and V2 is CR10, in which R10 = chlorine and R4 is R33.
A compound of formula III where Z is Z1, V1 is CR9 and V2 is CR10, may also be prepared by formylation of a compound of formula XXXI
Figure imgf000027_0001
Ar in which R37 is hydrogen, e.g. with dimethylformamide and phosphorous oxychloride.
A compound of formula XXXI, in which R37 is hydrogen, cyano, alkoxycarbonyl or an optionally protected formyl group, may be prepared by reaction of a compound of formula XXXII
(XXXII)
Figure imgf000027_0002
I
H in which R37 is hydrogen, cyano, alkoxycarbonyl or a protected formyl group, with a compound of formula Ar-R32, where R32 is a leaving group, such as halogen, especially chlorine or fluorine.
A compound of formula XXXII may be prepared by a variety of methods known in the art for synthesis of pyrrole rings such as those described in Comprehensive Heterocyclic Chemistry Volume 4, ed. Katritzky and Rees, Chapter 3.06, pp 313, Pergamon 1984.
A compound of formula XXXI in which R4 and R10 are optionally substituted alkyl can also be prepared by reaction of a compound of formula XXXIII
R4-CO-CH(R9)-CH2-CO-R10 (XXXIII) with a compound Ar-NH2, in the presence of an acid catalyst.
A compound of formula III in which Z is Z1, V1 is CR9 and V2 is CR10, where R9 is cyano, R4 is hydrogen and R10 is amino may be prepared by hydrolysing a compound of formula XXXIV NC_ R38 Sj (XXXIV) \
N NH*,
I
Ar in which R38 is a bis(alkylthio)methyl or bis(arylthio)- methyl group.
A compound of formula XXXIV may be prepared from a compound of formula XXXIV in which R38 is hydrogen, by reaction with a tris(alkylthio)methane or tris(arylthio)- methane in the presence of a Lewis acid, e.g. dimethyl( ethylthio) sulfonium tetrafluoroborate.
A σompound-of formula XXXIV'in which R38 is hydrogen, may be prepared by reaction of formylsuccinonitrile or its alkali metal salt with Ar-NH2.
A compound of formula XXXI in which R9 is a formyl group, R4 is an amino group, R10 is hydrogen and R37 is a cyano group (prepared as above) may be transformed using methods for conversion of formyl groups known to those skilled in the art. For example, the formyl group may be converted to a difluoromethyl group using diethylaminosulfur trifluoride.
A compound of formula XXXI in which R9 is R19S, R4 is amino, R10 is hydrogen and R37 is cyano may be prepared by reacting the corresponding compound in which R9 is hydrogen with a sulfenyl halide of formula R19S-Hal (where Hal represents halogen) in the presence of an acid acceptor, e.g. a tertiary amine.
A compound of formula XXXI in which R4 is amino, R10 is hydrogen and R37 is cyano may be halogenated to the corresponding compound in which R10 is halogen or sulfenylated using a sulfenyl halide of formula R19S-Hal to the corresponding compound in which R10 is R19S.
A compound in which R9, R4 or R10 represents a group of formula R19S0 or R19S02 may be prepared by oxidising the corresponding compound in which R9, R4 or R10 represents R19S, using, for example a per-acid.
The compound of formula III in which Z is Z3 or Z4 are known or can be prepared by known means, as described for example in EP 259 048 and 396 250.
Compounds of formula I may also be prepared by reacting a compound of formula XXXV
Figure imgf000029_0001
where Z' is the heterocyclic radical Z, in which the Ar is replaced by H, with a compound Ar-R32, where R32 is a leaving group, such as halogen, e.g. fluorine or chlorine, in the presence of a base. R3 may be a protecting group such as those described in "Protective Groups in Organic Chemistry" by T W Greene, published by John Wiley and Sons.
The compound of formula XXXV, may be prepared in a similar manner to that previously described for the preparation of compound I, e.g. starting from a compound Z'CHO, reacting this with H2N-CR1=CR2-NH2 and ring closing the resulting compound. Other methods for preparing the compound of formula XXXV will be readily apparent those skilled in the art.
A compound of formula I where p is 0, Z is Z5, Y is NR12 and R12 is hydrogen, may be prepared from a compound of formula X, where R26 is halogen, preferably chlorine, by reaction with a metal thiocyanate, preferably sodium, thiocyanate, in the presence of a base, e.g. triethylamine. This compound may be further derivatised, e.g. by alkylation or acylation, to give other values of R12.
A compound of formula I where p is 0, Z is Z5 and Y is 0, W3 is S and W4 is C, may be prepared by heating a compound of formula XXXVI
(XXXVI)
Figure imgf000030_0002
Figure imgf000030_0001
Ar where Y' is NNO, in a solvent.
The compound of formula XXXVI may be prepared by diazotising a compound of formula I where p is 0, Z is Z , Y is NH, W3 is S and W4 is C, e.g. by reaction with a nitrite, e.g. sodium nitrite, in acetic acid.
A compound of formula III, where Z is Z5 and ϊ is O, W4 is C and W3 is NR40, can be prepared for example by reduction of a compound of formula XXXVII (XXXVII )
Figure imgf000031_0001
where R24 is an ester forming group such as alkyl, e.g. ethyl, using general methods indicated above.
The compound of formula XXXVII can be obtained by reaction of the compound of XVIII with potassium cyanate, followed by alkylation or by reaction with a substituted isocyanate of formula R^NCO.
A compound of formula III, in which Z is Z5 and Y is 0, W4 is C and W3 is -CR41=CR42-, can be prepared for example by reduction of a compound of formula XXXIX
(XXXIX)
Figure imgf000031_0002
Ar where R24 is an ester forming group such as alkyl, e.g. ethyl, R41 is methyl and R42 is hydrogen, using general methods indicated above.
The compound of formula XXXIX can be obtained by reaction of the compound of formula XIX with triethyl phosphonoacetate and sodium hydride in tetrahydrofuran.
A compound of formula III, in which p is 0, Z is Z5 and Y is 0, W4 is S and W3 is NH, can be prepared for example by reduction of a compound of formula XXXX (XXXX)
Figure imgf000032_0001
N i
Ar where R24 is an ester forming group such as alkyl, e.g. ethyl, using general methods indicated above.
The compound of formula XXXX can be obtained by reaction of the compound of XVII with thionyl chloride.
Compounds of formula I where R1, R2 and R3 are hydrogen may be obtained by reaction of a compound of formula XXXXI
Z-C .HC1 (XXXXI)
OEt with a compound of formula XXXXII H2N-CH2-CH(OMe)2 (XXXXII)
The compound of"formula XXXXI may be prepared from a compound of formula IV, where R23 is cyano by reaction with e.g. gaseous hydrogen chloride in ethanol.
The compound of formula IV is known or may be prepared in known manner.
A compound of formula I, where R2 and R3 are hydrogen, may be obtained by reaction of a compound of formula III, with a compound of formula R l_C0-.cHBr2 and ammonia.
Compounds where R1 and/or R2 are hydrogen may be modified by known methods such as e.g. electrophilic substitution reactions to give compounds of formula I where R1 and/or R2 are e.g. halogen, nitro etc. These groups may be modified by methods known to those skilled in the art to give other R1 and R2 groups. In some cases it may be necessary to have a suitable protecting group at R3, which can subsequently be removed, in known manner.
Thus, where R1 is e.g. trifluoromethyl, this may be further reacted with ammonia to give a compound of formula I, where R1 is cyano.
Where R1 is e.g. cyano or trifluoromethyl and R2 is hydrogen, the compound may be reacted with a brominating agent, e.g. N-bromosuccinimide, to give a compound of formula I, where R2 is bromo.
A compound of formula I in which R3 is H may be further modified in known manner, e.g. by alkylation to give other R3 groups.
A compound of formula I in which p is 1 may be obtained by reaction of a compound of formula XXXXIII
Z-AH (XXXXIII) with a compound of formula XXXXIV
R39— (XXXXIV)
Figure imgf000033_0001
in which R39 is a leaving group, such as a halogen, under basic conditions.
A compound of formula XXXXIV may be formed from a compound of formula XXXXV
539 (XXXXV)
R^
Figure imgf000033_0002
H by a variety of known methods, e.g. as described in "Protective Groups in Organic Synthesis" by T W Greene, published by John Wiley and Sons.
Where, in a compound of formula XXXXIV, the group R3 is a protecting group, e.g. containing silicon, the resulting compound of formula I may be optionally further modified in known manner, e.g. by hydrolysis or reaction with a source of fluoride ion to give compounds of formula I in which R3 is H.
Where A is S, this group can be oxidised using a suitable oxidising agent, e.g. m-chloroperbenzoic acid.
It will be evident to those skilled in the art that in compounds of formula I where R1 and R2 are different and R3 is H, tautomeric forms exist. These tautomers and any mixture thereof form part of the invention. Similarly in compounds of formula I where R1 and R2 are different and R3 is not hydrogen, then isomers are possible. These isomers and any mixture thereof comprise part of the invention.
The compounds of formula I in which R3 is hydrogen may form pesticidally and pharmaceutically acceptable salts with organic or inorganic bases, especially where R1 and/or R2 are electron withdrawing groups. These salts also form part of the invention.
Pesticidally acceptable salts means salts, the cations of which are known and accepted in the art as being suitable for the formation of salts of pesticidally active acids for use in agriculture or horticulture.
Similarly, pharmaceutically acceptable salts means salts, the cations of which are known and accepted in the art as being suitable for the formation of salts of biologically active acids for use in veterinary or human medicine.
Generally the salt is an alkali metal, alkaline earth metal, quaternary ammonium or an amine salt. Amine salts include salts derived from primary, secondary and tertiary amines, including amino sugars, such as N-methylglucamine. Salts may be prepared by reacting the compound of the invention, in known manner, with a suitable base.
It will be apparent that substituents on the various Z groups in a compound of formula I or its precursors may be modified in known manner to give other desired substituents. Thus for example compounds containing an alkoxycarbonyl group may be reduced, e.g. with diisobutylaluminium hydride at low temperature to give to give the corresponding carboxaldehyde. Alternatively they may be reduced by methods known in the art, e.g. using lithium aluminium hydride, diisobutylaluminium hydride or zirconium borohydride (prepared in situ from zirconium tetrachloride and sodium borohydride) in an inert solvent, such as tetrahydrofuran, to give a compound containing a hydroxymethyl group. This compound can then be oxidised to the carboxaldehyde, e.g. using pyridinium dichromate or manganese dioxide. Carboxaldehydes can be converted to oximes which in turn can be dehydrated to the corresponding nitrile. Compounds containing methyl groups may be halogenated to convert the methyl to halomethyl, in known manner and the halomethyl group can then be oxidised to give the corresponding carboxaldehyde.
Compounds and intermediates where Z is Z5 and Y is S may be obtained from the corresponding compound where Y is O, by reaction with a sulfurising agent such as Lawesson's reagent. The invention is illustrated in the following examples. Structures of isolated novel compounds were confirmed by elemental and/or other appropriate analyses.
Example 1 A solution of 3-[(2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2 ,6-dichloro-4-trifluoromethylphenyl)-2 ,5-dimethyl- pyrrole, (0.53 g) and 2,3-dichloro-5,6-dicyano- 1,4-benzoquinone (0.28 g) in dioxane was heated under reflux for 6 hours. The mixture was poured into water and extracted with ethyl acetate. The extract was washed with dilute hydrochloric acid, dried and evaporated to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-(4,5-dicyano- lH-imidazol-2-yl)-2,5-dimethylpyrrole, as a gum. (Compound la) .
In a similar manner there was obtained:
(i) 2,5-dichloro-l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-3-(4,5-dicyano-lH-imidazol-2-yl)-4-methylpyrrole, m.p. 115-120°. (Compound lb).
(ii) 2,5-dichloro-l-(2,6-dichloro-4-trifluoromethyl- phenyl)-4-(4,5-dicyano-lH-imidazol-2-yl)imidazole, m.p. 203-5°. (Compound lc)
(iii) 1-(2,6-dichloro-4-trifluoromethylphenyl)-
3-(4 ,5-dicyano-lH-imidazol-2-yl)-1H-1 , 2 ,4-triazole, m.p. 172-174°. (Compound Id)
(iv) 1-(2,6-dichloro-4-trifluoromethylphenyl)- 4-(4 ,5-dicyano-lH-imidazol-2-yl)-5-pyrrol-l-yl- lH-pyrazole, m.p. 216-219° (Compound le) . (v) 1-(2,6-dichloro-4-trifluoromethylphenyl)- 4-(4,5-dicyano-lH-imidazol-2-yl)-5-methylthio-lH-pyrazole, m.p. 192-196° (Compound If) .
(vi) 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl)- 4-(4,5-dicyano-lH-imidazol-2-yl)-3-ethoxycarbonyl- lH-pyrazole, m.p. 131-3°. (Compound lg) .
(vii) 5-bromo-l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-4-(4,5-dicyano-lH-imidazol-2-yl) imidazole, m.p. 236-241°. (Compound lh)
(viii) 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl)- 4-(4,5-dicyano-lH-imidazol-2-yl)-3-methoxycarbonyl- lH-pyrazole, m.p. 288-90°. (Compound li) . (cyclisation by method described in Example 6) .
(ix) 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4,5-dicyano-lH-imidazol-2-yl)-4-methylpyrrole, m.p. 135-138°. (Compound lj).
(x) 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4,5-dicyano-lH-imidazol-2-yl)-5-trichloromethyl- lH-l,2,4-triazole, m.p. 281-3° (dec.) (Compound Ik)
(xi) l-(2,6-dichloro-4-trifluoromethylphenyl)-
3-(4,5-dicyano-lH-imidazol-2-yl)-5-dichloromethyl- lH-l,2,4-triazole, m.p. 292-3° (dec.) (Compound 11). (xii) 1-(2,6-dichloro-4-trifluoromethylphenyl)- 4-(4,5-dicyano-lH-imidazol-2-yl)-3,5-bis(trifluoromethyl)- lH-pyrazole, m.p. 186-7°. (Compound lm) .
(xiii) 5-bromo-l-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4,5-dicyano-lH-imidazol-2-yl)-4-methoxy-lH-pyrazole, m.p. 213-6° (Compound In) . (xiv) 5-bromo-l-(2 ,6-dichloro-4-trifluoromethylphenyl)- 3-( ,5-dicyano-lH-imidazol-2-yl)-4-difluoromethoxy- lH-pyrazole, m.p. 265-8° (dec.) (Compound Ip) .
(xv) 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4 ,5-dicyano-lH-imidazol-2-yl)-5-methoxy-lH-pyrazole , m.p. 129-30° (Compound lq) .
(xvi) 5-chloro-l-(2 ,6-dichloro-4-trifluoromethylphenyl)- 3-(4 ,5-dicyano-lH-imidazol-2-yl)-4-difluoromethy1- lH-pyrazole, m.p. 193-7° (Compound lr) .
(xvii) 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4 ,5-dicyano-lH-imidazol-2-yl)-1H-1 , 2 ,4-triazole, m.p. 258-9°. (Compound is)
(xviii) 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4,5-dicyano-lH-imidazol-2-yl)-4-methoxy-lH-pyrazole, m.p. 220-3° (Compound It).
(xix) 1-(2,6-dichloro-4-trifluoromethylphenyl)-
3-(4,5-dicyano-lH-imidazol-2-yl)-4-difluoromethoxy-
IH-pyrazole, m.p. 272-5° (Compound lu) .
(xx) 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4,5-dicyano-lH-imidazol-2-yl)pyrrole, m.p. 212-4° (Compound lv) .
(xxi) 1-(2,6-dichloro-4-trifluoromethylphenyl)-
3-(4,5-dicyano-lH-imidazol-2-yl)-4,5-dihydro-4-methyl-
5-oxo-lH-l,2,4-triazole, m.p. 338-9°. (Compound lw) .
(xxii) l-(2,6-dichloro-4-trifluoromethylphenyl)-
4-(4,5-dicyano-lH-imidazol-2-yl)-3-methoxy-lH-pyrazole, m.p. 225-6°. (Compound lx) . (xxiii) 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl) 3-(4,5-dicyano-lH-imidazol-2-yl)-lH-pyrazole, m.p. 201-2° (Compound ly) .
(xxiv) 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4,5-dicyano-lH-imidazol-2-yl)-4-[ (dimethyl) (tert.- butyl)silyloxyJ-lH-pyrazole, m.p. 95-7°. (Compound lz) .
(xxv) 1-(2 ,6-dichloro-4-trifluoromethylphenyl)-
3-(4 ,5-dicyano-lH-imidazol-2-yl)-4,5-dihydro-4-ethyl-
5-oxo-lH-l,2,4-triazole, m.p. 230° (dec.) (Compound laa).
(xxvi) 3-(2,6-dichloro-4-trifluoromethylphenyl)-
5-(4,5-dicyano-lH-imidazol-2-yl)-2,3-dihydro-2-oxo- 1,3,4-oxadiazole, m.p. 242-244.5°. (Compound lbb) .
(xxvii) 5-(4,5-dicyano-lH-imidazol-2-yl)-2,3-dihydro- 3-(2-nitro-4-trifluoromethylphenyl)-2-oxo- 1,3,4-thiadiazole, m.p. 94.4° (dec). (Compound lcc).
Preparation of starting materials
a) Compound la - starting material
2,5-Dimethylpyrrole (2.29 ml) was stirred with sodium hydride (0.54 g of 60% dispersion in oil) for half an hour. l,3-Dichloro-2-fluoro-5-trifluoromethylbenzene (5 g) was added and the mixture heated under reflux for 2 hours. The mixture was poured into water and extracted with ethyl acetate. The extract was washed with water, dried and evaporated and the oil purified by silica gel chromatography to give 1-(2,6-dichloro-4-trifluoro¬ methylphenyl)-2 ,5-dimethylpyrrole, as an oil. This product (0.87 g) in dimethylformamide (10 ml) was added to mixture of phosphorus oxychloride (0.29 ml) and dimethylformamide (0.24 ml) and the mixture stirred for 15 minutes at 0°. The mixture was poured into aqueous potassium carbonate, extracted with ether and the extract worked up to give 1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-2,5-dimethylpyrrole-3-carboxaldehyde, m.p. 93-95°. A mixture of this product (0.74 g) and diaminomaleonitrile (0.24 g) and a trace of p-toluenesulfonic acid in methanol was stirred at room temperature for 18 hours. The solvent was removed and the residue purified by silica gel chromatography to give 3-[(2-amino-l,2-dicyanoethenyl- imino)methyl]-1-(2 ,6-dichloro-4-trifluoromethylphenyl)- 2,5-dimethylpyrrole, m.p. 130-131°.
b) Compound lb - starting material 3-Methoxycarbonyl-4-methylpyrrole was reacted with l,3-dichloro-2-fluoro-5-trifluoromethylbenzene, in the presence of sodium hydride to give l-(2,6-dichloro- 4-trifluoromethylphenyl)-3-methoxycarbony1-4-methyl- pyrrole, m.p. 123-5°. A solution of this product (7.02 g) in ether (150 ml), was treated with sulfuryl chloride (2.9 ml) at 0°. The mixture was stirred for % hour at this temperature and then evaporated. The residue was worked up to give 2,5-dichloro-l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-3-methoxycarbony1-4-methylpyrrole, m.p. 119-120°. This product (3.8 g) in dry tetrahydrofuran (30 ml) at -78°, was treated with diisobutylaluminium hydride in hexane (27 ml of one molar solution) . The mixture was stirred for 3 hours at this temperature, warmed to room temperature, cooled to -10° and water (10 ml) added, followed by silica (25 g) . The mixture was allowed to warm to room temperature, filtered and the filtrate evaporated to give 2,5-dichloro-l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-3-hydroxymethyl-4-methylpyrrole, m.p. 93-5°. A solution of this (2.7 g) in chloroform (50 ml) was stirred for 24 hours with manganese dioxide. The mixture was filtered and the filtrate evaporated. The residue was worked up to give 1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-2,5-dichloro-4-methylpyrrole-3-carboxaldehyde, m.p. 107-8°, which itself was converted to 3-[(2-amino- 1,2-dicyanoethenylimino)methyl]-2,5-dichloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-methylpyrrole, m.p. 188-190°.
c. Compound lc - starting material
Sodium hydride (0.41 g of a 90% dispersion in oil) was added portionwise to a solution of 5-amino-4-ethoxy- carbonylimidazole (2.4 g) in dimethylformamide (30 ml), cooled in an ice-bath. A solution of 1,3-dichloro- 2-fluoro-5-trifluoromethylbenzene (4.0 g) in dimethylformamide (10 ml) was added dropwise and the mixture stirred overnight at room temperature. The solvent was removed under reduced pressure and the residue triturated with hexane. The mixture was then extracted with ethyl acetate and the extract worked up' to give 5-amino-l-(2 ,6-dichloro-4-trifluoromethylphenyl)- 4-ethoxycarbonylimidazole, m.p. 208-210°. This was treated with sulfuryl chloride in a similar manner to that described above to give 5-amino-2-chloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-ethoxycarbonyl- imidazole, m.p. 145-150°.
A solution of this product (3.7 g) in hydrochloric acid (60 ml) was treated with cuprous chloride (4.6 g) . The mixture was cooled on an ice/water bath and nitrosyl- sulfuric acid (11.8 g) , in sulfuric acid (20 ml), added. The mixture was stirred for 48 hours at room temperature, poured into ice and extracted with ethyl acetate. The extract was dried and evaporated and the residue worked up to give 2,5-dichloro-l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-4-ethoxycarbonylimidazole, as an oil. This was reduced in a similar manner to that described above to give 2 ,5-dichloro-l-( 2 ,6-dichloro-4-trifluoro¬ methylphenyl)-4-hydroxymethylimidazole, m.p. 133-7° , which in turn was oxidised in a similar manner to that described above to give 2,5-dichloro-l-(2,6-dichloro- 4-trifluoromethylphenyl)imidazole-4-carboxaldehyde, m.p. 81-85°, which itself was converted to 4-[(2-amino- 1,2-dicyanoethenylimino)methyl]-2,5-dichloro- l-(2,6-dichloro-4-trifluoromethylphenyl)imidazole, m.p. 213-5°.
d) Compound Id - starting material Sodium nitrite (45 g) in concentrated sulfuric acid (340 ml) was added to a solution of 2,6-dichloro- 4-trifluoromethylaniline (140 g) in acetic acid (550 ml) , whilst maintaining the temperature below 25°. The mixture was stirred at room temperature for 1 hour and added to a solution of ethyl acetoacetate (80 g) , sodium acetate
(180 g) , ethanol (300 ml) and ice water (3 litres) , and the mixture stirred for 1 hour. The precipitate was collected and combined with further precipitate (resulting from allowing the filtrate to stand) , to give ethyl 2-(2,6-dichloro-4-trifluoromethylphenylhydrazono)- 3-oxobutanoate.
This product was added to a mixture of glacial acetic acid (30 ml) and acetic anhydride (180 ml) containing sodium acetate (81 g) . The mixture was cooled on an ice bath and bromine (40 g) in acetic acid (60 ml) was added dropwise. The mixture was stirred for 30 minutes at this temperature and then for 2 hours at room temperature. It was poured into ice water and allowed to stand over the weekend. The precipitate was filtered off to give ethyl 2-bromo- 2-(2,6-dichloro-4-trifluoromethylphenylhydrazono)acetate, m.p. 116-117°.
A suspension of this product (30g) in ethanol (150 ml) , was added to aqueous ammonia (500 ml) and water (500 ml) . The mixture was stirred for 10 minutes, the solid filtered off, triturated with hexane, filtered, dried and purified by silica gel column chromatography to give ethyl 2-amino- 2-(2,6-dichloro-4-trifluoromethylphenylhydrazono)acetate, m.p. 133-134°.
A mixture of this product (19 g) and triethyl orthoformate (28 g) was heated under reflux for 4 hours. After cooling, the mixture was added to hexane and the mixture cooled in a dry ice/acetone, the solid was filtered off to give 1-(2,6-dichloro-4-trifluoro ethyphenyl)-3-ethoxycarbonyl- lH-l,2,4-triazole, m.p. 128-129°.
This product (11.5 g) in dry tetrahydrofuran (65 ml) at -78°, was treated with diisobutylaluminium hydride in hexane (30 ml of one molar solution) whilst maintaining the temperature at below -65°. The mixture was allowed to warm to -10° over 1 hour and water (10 ml) added, followed by silica (10 g) . The mixture was allowed to warm to room temperature, filtered and the filtrate evaporated. The residue was triturated with hexane and the solid collected to give 1-(2,6-dichloro-4-trifluoromethylphenyl)- 1H-1,2,4-triazole-3-carboxaldehyde, m.p. 126-127°.
This was then reacted with diaminomaleonitrile, as described above, to give 3-[(2-amino-l,2-dicyanoethenyl- imino)methyl]-1-(2,6-dichloro-4-trifluoromethylphenyl)- lH-l,2,4-triazole, m.p. 259-261°.
e. Compound le - starting material
A solution of 2,6-dichloro-4-trifluoromethylphenyl- hydrazine (10 g) and ethyl 2-cyano-3-ethoxyacrylate (7.0 g) in absolute ethanol (200 ml) was heated under reflux with stirring for 24 hours. Evaporation of solvent and recrystallisation from diisopropyl ether gave ethyl 5-amino-l-(2,6-dichloro-4-trifluoromethylphenyl)- lH-pyrazole-4-carboxylate, m.p. 131-134°.
A mixture of this compound (7.1 g) , 2,5-dimethoxy- tetrahydrofuran (7.8.ml) and acetic acid (1.6 ml) was heated under reflux, under nitrogen overnight. The mixture was added to water and extracted with ether. The extract was worked up to give ethyl 1-(2,6-dichloro-4-trifluoro¬ methylphenyl)-5-pyrrol-l-yl-lH-pyrazole-4-carboxylate, m.p. 131-134°. A solution of this product (6.4 g) in tetrahydrofuran (25 ml) was added dropwise to mixture of zirconium chloride (4.3 g) in tetrahydrofuran (65 ml) to which had been added sodium borohydride (2.9 g) under nitrogen. The mixture was stirred at room temperature overnight added to ice water and worked up to give l-(2,6-dichloro-
4-trifluoromethylphenyl)-4-hydroxymethyl-5-pyrrol-l-yl- lH-pyrazole. A mixture of this compound (2.2 g) and manganese dioxide (7.9 g) in chloroform (40 ml) was stirred at room temperature for two days. It was then filtered, evaporated and a solution of the residue in dichloromethane purified by silica gel column chromatography to give
1-(2,6-dichloro-4-trifluoromethylphenyl)-5-pyrrol-l-yl- lH-pyrazole-4-carboxaldehyde, m.p. 159-163°.
This was treated with diaminomaleonitrile in a similar manner to that previously described to give 4-[(2-amino- 1,2-dicyano-ethenylimino)methyl]-1-(2,6-dichloro- 4-trifluoromethylphenyl)-5-pyrrol-l-yl-lH-pyrazole, m.p. 212-214°.
f. Compound If - starting material t-Butyl nitrite (3.3 ml) was added with stirring to a solution of ethyl 5-amino-l-(2,6-dichloro-4-trifluoro¬ methylphenyl)-lH-pyrazole-4-carboxylate, prepared as described above, and dimethyl disulfide (3.45 ml) in chloroform (100 ml) . The mixture was stirred for one hour, washed with brine, the organic layer evaporated and the residue purified by silica gel column chromatography to give ethyl 1-(2 ,6-dichloro-4-trifluoromethylphenyl)- 5-methylthio-lH-pyrazole-4-carboxylate, as an oil. This was reduced as described above to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxymethyl- 5-methylthio-lH-pyrazole, as an oil.
This product (1.1 g) in dichloromethane (50 ml) was stirred with pyridinium dichromate (1.75 g) for 18 hours at room temperature. Ether (150 ml) and silica (5 g) were added and the mixture stirred for 45 minutes, filtered, evaporated and the oil which solidified was triturated with hexane to give 1-(2,6-dichloro-4-trifluoro¬ methylphenyl)-5-methylthio-lH-pyrazole-4-carboxaldehyde, m.p. 88-89°. This was treated with diaminomaleonitrile in a similar manner to that previously described to give 4-[(2-amino- 1,2-dicyanoethenylimino)methyl]-1-(2,6-dichloro- 4-trifluoromethylphenyl)-5-methylthio-lH-pyrazole, m.p. 225-228°.
g. Compound lg - starting material Sodium nitrite (13.8 g) was added to a solution of 2,6-dichloro-4-trifluoromethylaniline (46 g) in concentrated hydrochloric acid (150 ml) at 0°. The mixture was stirred for 15 minutes, filtered into a flask maintained at 0° and then added slowly to a mixture of diethyl acetylsuccinate (43.2 g) in water (500 ml) and sodium acetate (270 g) in water (1 L) . The mixture was allowed to heat up to room temperature over an hour and aqueous ammonia (25%; 150 ml) was added and the mixture heated at 60° for 1 hour. It was extracted with diethyl ether and the extract worked up to give an oil which was passed though a silica gel column to remove the dark baseline. The purified material was heated under reflux for 48 hours with p-toluenesulfonic acid (5 g) in ethanol. The solvent was evaporated and the residue recrystallised from ethyl acetate to give 1-(2,6-dichloro-4-trifluoro¬ methylphenyl)-3-ethoxycarbonyl-lH-pyrazolin-5(4H)-one, m.p. 265-6°. This compound (5.72 g) was added to a preformed mixture of phosphorus oxychloride (71.6 ml) and dimethylformamide (1.35 ml) . The resulting mixture was then heated under reflux overnight and excess phosphorus oxychloride removed under reduced pressure. Ice was added to the residue and the mixture extracted with dichloro- methane. The extract was worked up to give an oil which was passed through a silica gel column using ether as eluent and the fraction having an Rf value of 0.83 was collected, which was shown by nmr to be 5-chloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-ethoxy- carbonyl-4-formyl-lH-pyrazole.
This product was treated, without further purification, with diaminomaleonitrile in a similar manner to that previously described to give 5-chloro-l-(2,6-dichloro- 4-trifluoromethylphenyl)-3-ethoxycarbonyl-4-[ (2-amino- 1,2-dicyanoethenylimino)methyl]-lH-pyrazole, m.p. 201-3°.
h) Compound in - starting material t-Butyl nitrite (1.2 ml) was added portionwise to a solution of 5-amino-l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-4-ethoxycarbonylimidazole, prepared as described above, (1.22 g) in bromoform (6 ml), maintained under nitrogen. The mixture was stirred at room temperature overnight, the solvent evaporated under reduced pressure and the residue extracted with dichloromethane. The extracts were worked up to give 5-bromo-l-(2,6-dichloro- 4-trifluoromethylphenyl)-4-ethoxycarbonylimidazole, m.p. 99-101°.
This product was then reduced with diisobutylaluminium hydride in a similar manner to that previously described to give 5-bromo-l-(2,6-dichloro-4-trifluoromethylphenyl)- 4-formylimidazole, m.p. 129-131°.
This product was treated with diaminomaleonitrile in a similar manner to that previously described to give 4-[ (2-amino-l,2-dicyanoethenylimino)methyl]-5-bromo- 1-(2,6-dichloro-4-trifluoromethylphenyl)imidazole, m.p. 195-200°. i. Compound li - starting material
Dimethylformamide dimethyl acetal (16 ml) was added dropwise to a solution of l-(2,6-dichloro-4-trifluoro¬ methylphenyl)-3-methoxycarbonyl-lH-pyrazol-5-one. The mixture was stirred overnight at room temperature, evaporated and the residue worked up to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(dimethyl- aminomethylene)-3-methoxycarbonyl-lH-pyrazol-5-one , m.p 223-224°.
A mixture of this product (31.89 g) and phosphorus oxychloride (375 ml) was heated under reflux for 16 hours and excess phosphorus oxychloride removed under reduced pressure. Ice was added to the residue and the mixture extracted with ethyl acetate. The extract was worked up to give 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl)- 3-methoxycarbonyl-4-formyl-lH-pyrazole, m.p. 138.5-139°.
This product was treated with diaminomaleonitrile in a similar manner to that previously described to give 4-[(2-amino-l,2-dicyanoethenylimino)methyl]-5-chloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-methoxy- carbonyl-lH-pyrazole, m.p. 209.4-210.5°.
i. Compound li - starting material
1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-methoxy- carbonyl-4-methylpyrrole was reduced as described above to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-hydroxy- methy1-4-methylpyrrole, m.p. 87-9°. This in turn was oxidised to 1-(2,6-dichloro-4-trifluoromethylphenyl)- 4-methylpyrrole-3-carboxaldehyde, m.p. 90-94°, which itself was converted to 3-[(2-amino-l,2-dicyanoethenyl- imino)methyl]-1-(2,6-dichloro-4-trifluoromethylphenyl)- 4-methylpyrrole, m.p. 174-7°. k and 1. Compounds lk and 11 - starting materials A mixture of ethyl 2-amino-2-(2,6-dichloro-4-trifluoro¬ methylphenylhydrazono)acetate (10 g) and trichloroacetic anhydride (30 ml) was heated at 200° for 1% hours. It was added to ice-water stirred for 1% hours and the solid collected and treated with diisopropyl ether on a steam bath and cooled in ice and filtered to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-ethoxycarbonyl- 5-trichloromethyl-lH-l,2,4-triazole, m.p. 143-4°.
This was then reduced with lithium borohydride, in a manner similar to that described in the preparation of the starting material for compound Is. NMR indicated that there was obtained a crude mixture, of..l-(2,6-dichloro- 4-trifluoromethylphenyl)-3-hydroxymethyl-5-trichloro- methyl-lH-l,2,4-triazole and 1-(2,6-dichloro-4-trifluoro¬ methylphenyl)-5-dichloromethyl-3-hydroxymethyl- 1H-1,2,4-triazole.
This mixture was treated with pyridinium dichromate to give a crude mixture of l-(2,6-dichloro-4-trifluoromethyl- phenyl)-5-trichloromethyl-lH-l,2,4-triazole-
3-carboxaldehyde and 1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-5-dichloromethyl-lH-l,2,4-triazole- 3-carboxaldehyde.
This mixture was then reacted with diaminomaleonitrile, as described above, followed by purification by silica gel column chromatography to give 3-[ (2-amino-l,2-dicyano- ethenylimino)methyl]-1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-5-trichloromethyl-lH-l,2,4-triazole and 3-[(2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2,6-dichloro-4-trifluoromethylphenyl)-5-dichloromethyl- 1H-1,2 ,4-triazole. m. Compound 1m - starting material Ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3,5-bis(trifluoromethyl)-lH-pyrazole-4-carboxylate was reduced with diisobutylaluminium hydride in a similar manner to that previously described, to give l-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxymethyl- 3,5-bis(trifluoromethyl)-lH-pyrazole, m.p. 97-8°. This in turn was oxidised, using pyridinium dichromate, to l-(2,6-dichloro-4-trifluoromethylphenyl)- 3,5-bis(trifluoromethyl)-lH-pyrazole-4-carboxaldehyde, m.p. 60-61°, which itself was converted to 4-[ (2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3,5-bis(trifluoromethyl)-lg-pyrazole, m.p..176-7°.
n) Compound In - starting material
Ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxy- lH-pyrazole-3-carboxylate was brominated with N-bromosuccinimide in chloroform to give ethyl 5-bromo- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxy- lH-pyrazole-3-carboxylate, m.p. 139-140°. This was then methylated using methyl iodide/sodium hydride in tetrahydrofuran to give ethyl 5-bromo-l-(2,6-dichloro- 4-trifluoromethylphenyl)-4-methoxy-lH-pyrazole- 3-carboxylate, m.p. 91-5°. This was reduced with zirconium tetrachloride/sodium borohydride to give 5-bromo-
1-(2,6-dichloro-4-trifluoromethylphenyl)-3-hydroxymethyl- 4-methoxy-lH-pyrazole, m.p. 99-100°. This in turn was oxidised, using pyridinium dichromate, to 5-bromo- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-methoxy- lg-pyrazole-3-carboxaldehyde, m.p. 62-3°, which itself was converted to 3-[(2-amino-l,2-dicyanoethenylimino)methyl]- 5-bromo-l-(2,6-dichloro-4-trifluoromethylphenyl)- 4-methoxy-lH-pyrazole, m.p. 148-150°. p. Compound lp - starting material
Ethyl 5-bromo-l-(2,6-dichloro-4-trifluoromethylphenyl)-4- hydroxy-lH-pyrazole-3-carboxylate, prepared as above was treated with chlorodifluoromethane in the presence of sodium hydroxide to give 5-bromo-l-(2,6-dichloro-
4-trifluoromethylphenyl)-4-difluoromethoxy-lH-pyrazole- 3-carboxylic acid, m.p. 131-4°. This was reduced with zirconium tetrachloride/sodium borohydride to give to give 5-bromo-l-(2,6-dichloro-4-trifluoromethylphenyl)- 3-hydroxymethyl-4-difluoromethoxy-lH-pyrazole, m.p. 86-8°. This in turn was oxidised, using pyridinium dichromate, to 5-bromo-l-(2,6-dichloro-4-trifluoromethylphenyl)- 4-difluoromethoxy-lH-pyrazole-3-carboxaldehyde, m.p. 55-7°, which itself was converted to 3-[(2-amino- 1,2-dicyanoethenylimino) ethyl]-5-bromo-l-(2,6-dichloro- 4-trifluoromethylphenyl)-4-difluoromethoxy-lH-pyrazole, m.p. 115-8°.
q. Compound lq - starting material Ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)- 4,5-dihydro-5-oxo-lH-pyrazole-3-carboxylate, was treated with dimethyl sulfate/sodiu hydride to give ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-5-methoxy- lH-pyrazole-3-carboxylate, m.p. 127-8°.
This was reduced with diisobutylaluminium hydride to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-5-methoxy- lH-pyrazole-3-carboxaldehyde, m.p. 96-8°, which itself was converted to 3-[ (2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2,6-dichloro-4-trifluoromethylphenyl)-5-methoxy- lH-pyrazole, m.p. 235-8°. r. Compound lr - starting material Diethylaminosulfur trifluoride (17.4. l) was added dropwise to a solution of 5-chloro-l-(2,6-dichloro- 4-trifluoromethylphenyl)-3-methoxycarbonyl-4-formyl- lH-pyrazole (18.05 g) in dichloromethane (150 ml).
The mixture was stirred for room temperature, overnight, water added and extracted with ethyl acetate. The extract was dried and evaporated and the residue worked up to give 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl)- 3-methoxycarbonyl-4-difluoromethyl-lH-pyrazole, m.p. 119-120°. This was reduced with diisobutylaluminium hydride to give 5-chloro-l-(2,6-dichloro-4-trifluoro¬ methylphenyl)-3-hydroxymethyl-4-difluoromethyl- lH-pyrazole, m.p.. 76--8°.
This in turn was oxidised, using pyridinium dichromate, to 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl)- 4-difluoromethyl-lH-pyrazole-3-carboxaldehyde, m.p. 77-9°, which itself was converted to 3-[ (2-amino-1,2-dicyano¬ ethenylimino)methyl]-5-chloro-l-(2,6-dichloro-4-trifluoro- methylphenyl)-4-difluoromethyl-lH-pyrazole, m.p. 210-212°.
s) Compound Is - starting material
A mixture of ethyl 2-bromo-2-(2,6-dichloro-4-trifluoro¬ methylphenylhydrazono)acetate (80 g) and potassium cyanate (34.4 g) in methanol (2 1) was heated under reflux for 6 hours and allowed to stand at room temperature overnight. Hydrochloric acid (40 ml) was added and the mixture heated under reflux for 2 hours. The solvent was evaporated, water added and the solid collected, washed with hexane and dried to give l-(2,6-dichloro-4-trifluoromethyl- phenyl)-3-methoxycarbonyl-4 ,5-dihydro-5-oxo- lH-l,2,4-triazole, m.p. 230-1°.
Lithium borohydride (4.3 g) was added to a solution of this product (35 g) in dry tetrahydrofuran (700 ml) . The mixture was stirred for % hour at room temperature, and then heated under reflux for 2 hours. It was poured into ice/hydrochloric acid and extracted with ethyl acetate. The extract was dried and evaporated and the residue worked up to give 1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-4,5-dihydro-3-hydroxymethyl-5-oxo- lH-l,2,4-triazole, m.p. 231-2°.
A mixture of this product (21 g) and phenylphosphonic dichloride (75 ml) was heated at 180-185° overnight. It was poured into water and extracted with ethyl acetate. The extract was dried and evaporated and the residue worked up to give 5-chloro-3-chloromethyl-l-(2,6-dichloro- 4-trifluoromethylphenyl)-1H-1,2,4-triazole, m.p. 1-18-9°. A mixture of this product (7.5 g) , anhydrous trimethylamine N-oxide (6.2 g) and dimethyl sulfoxide (40 ml) was stirred for 1.25 hours at room temperature, poured into brine and extracted with ethyl acetate. The extract was dried and evaporated to give 5-chloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)- lH-l,2,4-triazole-3-carboxaldehyde, m.p. 85-6°.
This was then reacted with diaminomaleonitrile, as described above, to give 3-[ (2-amino-l,2-dicyanoethenyl- imino)methyl]-5-chloro-l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-1H-1,2,4-triazole, m.p. 240-2° (dec).
t) Compound It - starting material
Ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxy- lH-pyrazole-3-carboxylate was methylated using methyl iodide/sodium hydride in tetrahydrofuran to give ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-methoxy- lH-pyrazole-3-carboxylate, m.p. 148-151°. This was reduced with zirconium tetrachloride/sodium borohydride to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-hydroxymethyl- 4-methoxy-lH-pyrazole, m.p. 91-3°. This in turn was oxidised, using pyridinium dichromate, to l-(2,6-dichloro- 4-trifluoromethylphenyl)-4-methoxy-lH-pyrazole- 3-carboxaldehyde, m.p. 122-3°, which itself was converted to 3-[(2-amino-l,2-dicyanoethenylimino)methyl]-
1-(2,6-dichloro-4-trifluoromethylphenyl)-4-methoxy- lH-pyrazole, m.p. 178-9°.
u) Compound lu - starting material
Chlorodifluoromethane was bubbled through a mixture of ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxy- lH-pyrazole-3-carboxylate (10 g) and aqueous sodium hydroxide (100 ml of 2M) and dioxane (100 ml) . Solvent was evaporated, the residue acidified and the solid collected and dried to give l-(2,6-dichloro-4-trifluoromethyl- phenyl)-4-difluoromethoxy-lH-pyrazole-3-carboxylic acid, m.p. 177-8°.
This was reduced with zirconium tetrachloride/sodium borohydride to give 1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-3-hydroxymethyl-4-difluoromethoxy-lH-pyrazole, m.p. 77-8°. This in turn was oxidised, using pyridinium dichromate, to 1-(2,6-dichloro-4-trifluoromethylphenyl)- 4-difluoromethoxy-lH-pyrazole-3-carboxaldehyde, as an oil, which itself was converted to 3-[(2-amino-l,2-dicyano- ethenyli ino)methyl]-1-(2,6-dichloro-4-trifluoromethyl- phenyl)-4-difluoromethoxy-lH-pyrazole, m.p. 160-4°.
v. Compound lv - starting material A mixture of 2,6-dichloro-4-trifluoromethylaniline (11.5 g) , 2,5-dimethoxytetrahydrofuran-3-carboxaldehyde (8 g) and a trace of β-toluenesulfonic acid was heated at 90-110° under nitrogen for 1 hour. The mixture was purified by silica gel column chromatography to give 1-(2,6-dichloro-4-trifluoromethylphenyl)pyrrole- 3-carboxaldehyde, which itself was converted to 3-[ (2-amino-1,2-dicyanoethenylimino)methyl]- 1-(2,6-dichloro-4-trifluoromethylphenyl)pyrrole, m.p. 175-7°.
w. Compound lw - starting material 1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-methoxy- carbonyl-4,5-dihydro-5-oxo-lH-l,2,4-triazole, (prepared under the compound Is starting material) was methylated using methyl iodide/sodium hydride in dimethylformamide to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-methoxy- carbonyl-4,5-dihydro-4-methy1-5-oxo-lH-l,2,4-triazole, m.p. 188-9°.
This was reduced with lithium borohydride as previously described, to give l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)- ,5-dihydro-3-hydroxymethyl-4-methyl-5-oxo- lH-l,2,4-triazole, m.p. 150-1°.
This in turn was oxidised, using pyridinium dichromate, to 1-(2,6-dichloro-4-trifluoromethylphenyl)-4,5-dihydro- 4-methyl-5-oxo-lH-l,2,4-triazole-3-carboxaldehyde, which itself was converted to 3-[ (2-amino-l,2-dicyanoethenyl- imino)methyl]-l-(2,6-dichloro-4-trifluoromethylphenyl)- 4,5-dihydro-4-methyl-5-oxo-lH-l,2,4-triazole, m.p. 245-6°.
x. Compound lx - starting material A solution of 2,6-dichloro-4-trifluoromethylphenyl- hydrazine (2.6 g) and diethyl 2-cyanomalonate (2.4 g) in absolute ethanol (30 ml) was heated under reflux with stirring for 4 hours. Evaporation of solvent and work-up of the residue gave ethyl 5-amino-l-(2,6-dichloro- 4-trifluoromethylphenyl)-3-hydroxy-lH-pyrazole- 4-carboxylate, m.p. 198.5-202.5°. This was deaminated using t-butyl nitrite in tetrahydrofuran to give ethyl l-(2,6-dichloro- 4-trifluoromethylphenyl)-3-hydroxy-lH-pyrazo1e- 4-carboxylate, m.p. 153-6°, which in turn was methylated with methyl iodide/potassium carbonate in acetone to give ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-methoxy- lH-pyrazole-4-carboxylate, m.p. 97-9°.
This was reduced with zirconium tetrachloride/sodium borohydride to give l-(2,6-dichloro-4-trifluoromethyl- phenyl)-4-hydroxymethyl-3-methoxy-lH-pyrazole, m.p.
131.5-3°. This in turn was oxidised, using pyridinium dichromate, to 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3-methoxy-lH-pyrazole-4-carboxaldehyde, m.p 89-90°, which itself was converted to 4-[(2-amino-l,2-dicyano- ethenylimino)methyl]-1-(2,6-dichloro-4-trifluoromethy1- phenyl)-3-methoxy-lH-pyrazole, m.p. 210-2°.
y. Compound ly - starting material
A solution of 5-amino-3-cyano-l-(2^6-dichloro-4-trifluoro¬ methylphenyl)-lH-pyrazole (7 g) in ether (150 ml) at 0° was treated with copper (I) chloride (4.2 g) and nitrosylsulphuric acid (14 g) in concentrated sulphuric acid (35 ml). After 2 hours at 5-15°, the mixture was poured onto ice and the pH adjusted to 8 with aqueous ammonia. It was extracted with ethyl acetate and the extract worked up to give 5-chloro-3-cyano-
1-(2,6-dichloro-4-tri luoromethylphenyl)-lH-pyrazole, m.p. 91-3°.
This was reduced with diisobutylaluminium hydride to give 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl)- lH-pyrazole-3-carboxaldehyde, m.p. 81-3° which in turn was converted to 3-[(2-amino-l,2-dicyanoethenylimino)methyl]- 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl)- lH-pyrazole, m.p. 220-1°. z. Compound lz - starting material
Ethyl 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-hydroxy- lH-pyrazole-3-carboxylate and imidazole in dimethylformamide was reacted with (dimethyl) (tert.- butyl)silyl chloride to give, after work up, ethyl
1-(2,6-dichloro-4-trifluoromethylphenyl)-4-[ (dimethyl)- (tert.-butyl)-silyloxy]-lH-pyrazole, m.p. 73-76°.
This was reduced with lithium borohydride as previously described, to give l-(2,6-dichloro-4-trifluoromethyl- phenyl)-4-[ (dimethyl) (tert.-butyl)silyloxy]-
3-hydroxymethyl-lH-pyrazole-3-carboxylate, m.p. 39-41°.
This in turn was oxidised, using pyridinium dichromate, to l-(2,6-dichloro-4-trifluoromethylphenyl)-4-[ (dimethyl)- (tert.-butyl)silyloxy]-lH-pyrazole-3-carboxaldehyde, m.p. 111-112°, which itself was converted to 3-[(2-amino- 1,2-dicyanoethenylimino)methyl]-1-(2,6-dichloro- 4-trifluoromethylphenyl)-4-[ (dimethyl) (tert.-butyl)- silyloxy]-lH-pyrazole, m.p. 82-4°.
aa. Compound laa - starting material l-(2,6-Dichloro-4-trifluoromethylphenyl)-3-methoxy- carbony1-4,5-dihydro-5-oxo-lH-l,2,4-triazole, (prepared as for the compound Is starting material) was ethylated using ethyl iodide/sodium hydride in dimethylformamide to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-methoxy- carbonyl-4,5-dihydro-4-ethyl-5-oxo-lH-l,2,4-triazole.
This was reduced with lithium borohydride as previously described, to give 1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-4,5-dihydro-3-hydroxymethyl-4-ethyl-5-oxo- lH-l,2,4-triazole, m.p. 129-130°.
This in turn was oxidised, using pyridinium dichromate, to 1-(2,6-dichloro-4-trifluoromethylphenyl)-4,5-dihydro- 4-ethyl-5-oxo-lH-l,2,4-triazole-3-carboxaldehyde, which itself was converted to 3-[(2-amino-1,2-dicyanoethenyl¬ imino)methyl]-1-(2,6-dichloro-4-tri luoromethylphenyl)- 4,5-dihydro-4-ethyl-5-oxo-lH-l,2,4-triazole, m.p. 165-7°.
bb. Compound lbb - starting material
A solution of cinnamoyl chloride (32 g) in tetrahydrofuran (100 ml) was added dropwise to a solution of 2,6-dichloro- 4-trifluoromethylphenylhydrazine (46.8 g) and triethylamine (20 g) in tetrahydrofuran (200 ml) , cooled on an ice-water bath. The product was worked up to give N1-cinnamoyl-N2-(2,6-dichloro-4-trifluoromethylphenyl)- hydraziner m.p. 150° (dec). This was then ring closed using trichloromethyl chloroformate, in the presence of triethylamine, to give 3-(2,6-dichloro-4-trifluoro¬ methylphenyl)-5-styryl-2,3-dihydro-2-oxo-l,3,4-oxadiazole, m.p. 164-166°.
Ozone was bubbled through a solution of this product (8.5 g) in methanol (220 ml) maintained at -60°, over 2 hours. Dichloromethane (30 ml) was added, followed by dimethyl sulphide (2 ml) and the mixture allowed to warm to room temperature. The mixture was worked up to give 3-(2,6-dichloro-4-trifluoromethylphenyl)-2,3-dihydro- 2-oxo-l,3,4-oxadiazole-5-carboxaldehyde, which itself was converted to 3-[(2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2,6-dichloro-4-trifluoromethylphenyl)-2,3-dihydro- 2-oxo-l,3 ,4-oxadiazole. cc) Compound lcc - starting material
In a similar manner to that described in the preparation of the starting material for Compound Id 2-nitro- 4-trifluoromethylaniline was converted to ethyl 2-(2-nitro-4-trifluoromethylphenylhydrazono)-
3-oxobutanoate, which in turn was converted to ethyl 2-bromo-2-(2-nitro-4-trifluoromethylphenylhydrazono)- acetate, m.p. 68.5-69.5°. This was ring closed with potassium thiocyanate to give 5-ethoxycarbonyl-3-(2-nitro- 4-trifluoromethylphenyl)-1,3,4-thiadiazol-2-imine, m.p. 135.6-136.5°. This was treated in a manner similar to Example 13 to give 5-ethoxycarbonyl-3-(2-nitro- 4-trifluoromethylphenyl)-1,3,4-thiadiazol-2-one, m.p. 81.6-81.8°.
This was reduced with lithium borohydride as previously described, to give 5-hydroxymethyl-3-(2-nitro- 4-trifluoromethylphenyl)-l,3,4-thiadiazol-2-one, which in turn was oxidised, using pyridinium dichromate, to 4,5-dihydro-3-(2-nitro-4-trifluoromethylphenyl)-2-oxo- lH-l,3,4-thiadiazole-5-carboxaldehyde, which itself was converted to 3-[ (2-amino-l,2-dicyanoethenylimino)methyl]- 3-(2-nitro- -trifluoromethylphenyl)-4,5-dihydro-5-oxo- 1H-1 ,3,4-thiadiazole.
Example 2 l,l-Dibromo-3,3,3-trifluoroacetone (7 g) was added to a solution of sodium acetate trihydrate (7 g) in water (25 ml) and the resulting solution heated on a steam bath for 30 mins. The mixture was cooled to room temperature and added slowly to a solution of l-(2,6-dichloro- 4-trifluoromethylphenyl)-1H-1,2,4-triazole- 3-carboxaldehyde (6.8 g) and aqueous ammonia (30 ml) in methanol (60 ml) . The suspension was stirred for 3 hours, reduced in volume and water added. The solid was collected by filtration, purified by silica gel chromatography and recrystallised from ethyl acetate/hexane to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-(4-trifluoro- methyl-lH-imidazol-2-yl)-lH-l,2,4-triazole, m.p. 270-271°. (Compound 2a) .
In a similar manner there was obtained:
(i) 1-(2,6-dichloro-4-trifluoromethylphenyl)-
5-(4-trifluoromethyl-lH-imidazol-2-yl)-4-trifluoromethyl-
2(lH)-pyridone, m.p. 204-20 ^ "(Compound 2b).
(ii) 1-(2 ,6-dichloro-4-trifluoromethylphenyl)-5-methyl- thio-4-(4-trifluoromethyl-lH-imidazol-2-yl)-lH-pyrazole, m.p. 196-7°. (Compound 2c).
Example 3
Compound 2a (2 g) was heated at 70° in 5% aqueous ammonia (300 ml) and ethanol (40 ml) for 6 hours. The mixture was cooled and filtered. The filtrate was acidified with glacial acetic acid and the resulting white precipitate was filtered and dried. The product was recrystallised from acetonitrile to give l-(2,6-dichloro-4-trifluoro- methylphenyl)-3~(4-cyano-lH-imidazol-2-yl)- lH-l,2,4-triazole, m.p. 295-296°. (Compound 3a) In a similar manner,
(i) compound 9a, gave 4-(5-bromo-4-cyano-lH-imidazol- 2-yl)-1-(2,6-dichloro-4-trifluoromethylphenyl)-5-methyl- sulfonyl-lH-pyrazole, m.p. 193-4°. (Compound 3b). (ii) compound 2c gave 1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-4-(4-cyano-lH-imidazol-2-yl)-5-methylthio- lH-pyrazole, m.p. 171-4°. (Compound 3c).
Example 4
A mixture of compound 2a (2 g) , N-bromosuccinimide (0.86 g) and dimethylformamide was stirred at room temperature overnight. This mixture was then poured into water, extracted with ether and the extract worked up to give 3-(5-bromo-4-trifluoromethyl-lH-imidazol-2-yl)- 1-(2,6-dichloro-4-trifluoromethylphenyl)- lH-l,2,4-triazole, m.p. 154-156°. (Compound 4a).
In a similar manner,
(i) compound 3a gave 3-(5-bromo-4-cyano-lH-imidazol-2-yl)- 1-(2,6-dichloro-4-trifluoromethylphenyl)- lH-l,2,4-triazole, m.p. 85-87°. (Compound 4b).
(ii) compound 2b gave 5-(5-bromo-4-trifluoromethyl-
1-(2 ,6-dichloro-4-trifluoromethy1-phenyl)-lH-imidazol- 2-yl)-4-trifluoromethy1-2-pyridone, m.p. 251-253°. (Compound 4c) .
(iii) compound 2c gave 4-(5-bromo-4-trifluoromethyl- lH-imidazol-2-yl)-l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-5-methylthio-lH-pyrazole, m.p. 175-177°. (Compound 4d) .
(iv) compound 3c gave 4-(5-bromo-4-cyano-lH-imidazol- 2-yl)-1-(2,6-dichloro-4-trifluoromethylphenyl)- 5-methylthio-lH-pyrazole, m.p. 227-9°. (Compound 4e) . Example 5
A mixture of 2-[(amino) (2,6-dichloro-4-trifluoromethyl- phenylhydrazono)methyl]-4 ,5-dicyano-lH-imidazole (0.7 g) , acetic anhydride (20 ml) and acetic acid (15 ml) was heated under reflux for 6 hours, poured into water, extracted with ether and the extract worked up to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-(4,5-dicyano- lH-imidazol-2-yl)-5-methyl-lH-l,2, -triazole. (Compound 5a) .
Preparation of starting material for compound 5a
A suspension of 2,6-dichloro-4-trifluoromethylphenyl- hydrazine (28 g) in acetic acid (150 ml) was added with stirring "to a mixture of aqueous glyoxal~(40%; 225 g in water (750 ml) . The mixture was stirred for two hours and filtered to give crude (2,6-dichloro-4-trifluoromethyl- phenylhydrazono)acetaldehyde.
This product (10 g) was suspended in methanol (120 ml) and diaminomaleonitrile (3.8 g) added. The mixture was stirred at room temperature for 3% days and filtered. The solid was recrystallised from acetonitrile to give 2-amino- 3-[(2,6-dichloro-4-trifluoromethylphenylhydrazono)- ethylidenamino]maleonitrile, m.p. >150°.
This product (10.5 g) , nicotinamide (13.8 g) and N-chlorosuccinimide (7.5 g) in dimethylformamide (90 ml) was stirred at 55° for 10 minutes. The mixture was poured into water and the resulting solid was purified by column chromatography to give 2-[(chloro) (2,6-dichloro- 4-trifluoromethylphenylhydrazono)methyl]-4,5-dicyano- lH-imidazole, m.p. 207-8°.
This product (3 g) was treated with aqueous ammonia
(40 ml) and water (100 ml) , the mixture stirred for 5 minutes at room temperature, extracted with ethyl acetate and the extract dried and evaporated to give 2-[ (amino)- (2,6-dichloro-4-trifluoromethylphenylhydrazono)methyl]- 4,5-dicyano-lH-imidazole, m.p. 282-284°.
Example 6
A mixture of 5-[ (2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2 ,6-dichloro-4-trifluoromethylphenyl)-4-trifluoro- methyl-2(lH)-pyridone, (0.5 g) , N-chlorosuccinimide (0.27 g) and nicotinamide (0.15 g) in dimethylformamide (15 ml) was stirred at 60° for 3 hours. The mixture was added to water, extracted with ethyl acetate and the extract worked up to give, after recrystallisation from ethyl acetate/ hexane to give 1-(2,6-dichloro-4-trifluoro¬ methylphenyl)-5-(4,5-dicyano-lH-imidazol-2-yl)- 4-trifluoromethy1-2-pyridone, m.p. 279-282°. (Compound 6a)
In a similar manner
(i) 4-[ (2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2,6-dichloro-4-tri luoromethylphenyl)-3-methoxy- lH-pyrazole (starting material for compound lx) gave 5-chloro-l-(2,6-dichloro-4-trifluoromethylphenyl)-
4-(4,5-dicyano-lH-imidazol-2-yl)-3-methoxy-lH-pyrazole, m.p. 215°. (Compound 6b).
(ii) 4-[ (2-amino-l,2-dicyanoethenylimino)methyl]-
1-(2,6-dichloro-4-trifluoromethylphenyl)-3-difluoro- methoxy-lH-pyrazole gave 1-(2,6-dichloro-4-trifluoro¬ methylphenyl)-4-(4,5-dicyano-lH-imidazol-2-yl)- 3-difluoromethoxy-lH-pyrazole, m.p. 213-215°. (Compound 6c) .
Preparation of starting material for compound 6a A mixture of 1-(2,6-dichloro-4-trifluoromethylphenyl)- 5-formyl-4-trifluoromethyl-2-pyridone (1 g) and diaminomaleonitrile (0.27 g) and a trace of p-toluenesulfonic acid in methanol was stirred at room temperature for 4 hours. The mixture was evaporated and the residue recrystallised from ethyl acetate/hexane to give 5-[ (2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-trifluoro- methyl-2-pyridone, m.p. 246-248°.
Preparation of starting material for compound 6c In a similar manner to that used for the starting material to Compound lu, ethyl l-(2,6-dichloro-4-trifluoromethyl- phenyl)-3-hydroxy-lH-pyrazole-4-carboxylate was treated with chlorodifluoromethane to give l-(2,6-dichloro- 4-trifluoromethylphenyl)-3-difluoromethoxy-lH-pyrazole- 4-carboxylic acid, m.p. 106-108.5°.
This was reduced with zirconium tetrachloride/sodium borohydride to give 1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-3-difluoromethoxy-4-hydroxymethyl-lH-pyrazole, which was oxidised, using pyridinium dichromate, to l-(2j6-dichloro-4-trifluoromethylphenyl)-3-difluoro- methoxy-lH-pyrazole-4-carboxaldehyde, which itself was converted to 4-[(2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-difluoro- methoxy-lH-pyrazole.
Example 7
Sodium (0.17 g) was dissolved in ethanol (15 ml) and ethyl cyanoacetate (0.84 g) was added with stirring. The mixture was stirred for 10 minutes at room temperature and then 2-[(chloro) (2,6-dichloro-4-trifluoromethylphenyl¬ hydrazono)methyl]-4,5-dicyano-lH-imidazole (1 g; prepared as described above - see preparation of starting material for compound 5a) was added. The mixture was stirred at room temperature for 40 minutes and poured into dilute hydrochloric acid. The solid was filtered off, dried and recrystallised from acetonitrile to give 5-amino- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-ethoxy- carbonyl-3-(4,5-dicyano-lH-imidazol-2-yl)-lH-pyrazole, m.p. 290-1°. (Compound 7a).
In a similar manner: a) using methylsulfonylacetonitrile, there was obtained 5- amino-1-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4 ,5-dicyano-lH-imidazol-2-yl)-4-methyl- sulfonyl-lH-pyrazole, m.p. >350°. (Compound 7b).
b) using malononitrile, there was obtained
5-amino-4-cyano-l-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4,5-dicyano-lJ-imidazol-2-yl)-lH-pyrazole, m.p. >350°. (Compound 7c) .
Example 8 A mixture of vinyl butyl ether (1.13 ml) and triethylamine (1.21 ml) in toluene (2 ml) was added dropwise to a stirred suspension of 2-[ (chloro) (2,6-dichl ro- ... , 4-trifluoromethylphenylhydrazono)methyl]-4 ,5-dicyano- 1H-imidazole (1.75 g) in toluene (3 ml) at 90°. The mixture was heated at this temperature for 3 hours, cooled and filtered. 2N Hydrochloric acid was added and the mixture extracted with ethyl acetate. The extract was worked up to give 1-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-3-(4,5-dicyano-lH-imidazol-2-yl)-lH-pyrazole, m.p. 175-8°. (Compound 8a).
In a similar manner, using propen-2-yl methyl ether, there was obtained 1-(2,6-dichloro-4-trifluoromethylphenyl)- 3-(4,5-dicyano-12-imidazol-2-yl)-5-methyl-lH-pyrazole, m.p. 198-9° (Compound 8b). Example 9
A solution of oxone (i.io g) in water (35 ml) was added to a solution of compound 4d (0.65 g) in methanol (35 ml) kept on an ice bath. The mixture was stirred at room temperature for 18 hours, poured into water and extracted with dichloromethane. The extract was worked up to give 4-(5-bromo-4-trifluoromethyl-lH-imidazol-2-yl)- l-(2,6-dichloro-4-trifluoromethylphenyl)-5-methyl- sulfonyl-lH-pyrazole, m.p. 174-176°. (Compound 9a).
Example 10
A mixture of compound lg (2.9 g) and lithium hydroxide hydrate (0.5 g) in water (60 ml) and tetrahydrofuran (6 ml) was stirred for 5 hours at room temperature. It was then acidified with 2M hydrochloric acid (10 ml) , extracted with ether and the extract worked up to give 3-carboxy-5-chloro-l-(2,6-dichloro-4-trifluoromethyl¬ phenyl)-4-(4,5-dicyano-lH-imidazol-2-yl)-lH-pyrazole, m.p. 225-7°. (Compound 10a).
Example 11 A mixture of compound 10a (2.01 g) and thionyl chloride (40 ml) was heated under reflux for 2 hours. Excess thionyl chloride was evaporated and the residue dissolved in tetrahydrofuran (20 ml) and added to aqueous ammonia (40 ml) . The mixture was stirred at room temperature for 15 minutes and water (200 ml) was added. The mixture was extracted with ethyl acetate and the extract worked up to give 3-carbamoyl-5-chloro-l-(2,6-dichloro-4-trifluoro¬ methylphenyl)-4-(4,5-dicyano-lH-imidazol-2-yl)- lH-pyrazole, m.p. 262-4°. (Compound lla). Example 12
A mixture of 2-[ (chloro) (2,6-dichloro-4-trifluoromethy1- phenylhydrazono)methyl]-4,5-dicyano-lH-imidazole (l g; prepared as described above - see preparation of starting material for compound 5a), potassium thiocyanate (2.87 g) and methanol (30 ml) was heated under reflux for 15 hours. It was the poured into water containing dilute hydrochloric acid and filtered. The solid was dried and recrystallised from acetonitrile and dried in vacuo to give 3-(2,6-dichloro-4-trifluoromethylphenyl)-
5-(4,5-dicyano-lH-imidazol-2-yl)-1,3,4-thiadiazol-2-imine, m.p. >300°. (Compound 12a).
Example 13
Compound 12a (0.6 g) was dissolved in acetic acid (15 ml) and saturated aqueous sodium nitrite (4 ml) was added dropwise. The mixture was stirred for 1 hour at room temperature and then poured into water, neutralised with 10% aqueous sodium hydroxide and filtered to give 3-(2,6-dichloro-4-trifluoromethylphenyl)-5-(4 ,5-dicyano- lH-imidazol-2-yl)-N-nitroso-l,3,4-thiadiazol-2-imine. This was suspended in xylene (50 ml) and the mixture heated under reflux for 2 hours, cooled and filtered. The solid was purified by silica gel column chromatography to give 3-(2,6-dichloro-4-trifluoromethylphenyl)-5-(4,5-dicyano- lH-imidazol-2-yl)-l,3,4-thiadiazol-2-one, m.p. 263-4°. (Compound 13a) .
Example 14
A mixture of compound 12a (0.6 g) and acetic anhydride (30 ml) was stirred for 5 hours at 80° and the overnight at room temperature. It was poured into water, the mixture stirred at room temperature for 30 minutes, filtered, the solid dried, heated with boiling acetonitrile, filtered and dried to give N-acetyl-3-(2,6-dichloro-4-trifluoro¬ methylphenyl)-5-(4,5-dicyano-lH-imidazol-2-yl)- l,3,4-thiadiazol-2-imine, m.p. 300°. (Compound 14a).
Example 15 Compound lg was reduced with lithium borohydride in a manner similar to that described in the preparation of the starting material for compound is, to give 5-chloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano- lH-imidazol-2-yl)-3-hydroxymethyl-lH-pyrazole, m.p. 186-8°. (Compound 15a) .
Example 16
Compound 15a was oxidised with pyridinium dichromate in a manner similar to that previously described to give 5-chloro-l-(2 ,6-dichloro-4-trifluoromethylphenyl)- 4-(4,5-dicyano-lH-imidazol-2-yl)-3-formyl-lH-pyrazole, m.p. 260-2°. (Compound 16a).
Example 17 —
Hydroxylamine hydrochloride (0.12 g) and sodium acetate (0.24 g) in water (5 ml) was added to a solution of compound 16a (0.8 g) in ethanol (20 ml) . The mixture was stirred for 4 hours at room temperature, solvent evaporated, and the residue extracted with ethyl acetate. The extract was dried and evaporated and the residue worked up to give 5-chloro-l-(2,6-dichloro-4-trifluoro- methylphenyl)-4-(4,5-dicyano-lH-imidazol-2-yl)-
3-hydroximinomethyl-lH-pyrazole, m.p. 216°. (dec). (Compound 17a) .
Example 18
Trifluoroacetic anhydride (0.08 g) was added to a solution of Compound 17a (0.16 g) and pyridine (0.11 g) in dioxane (5 ml) . with ice-cooling. The mixture was stirred at room temperature overnight, and then heated under reflux for 4 hours. It was diluted with 2M hydrochloric acid, extracted with ether and the extract worked up to give 5-chloro- 3-cyano-l-(2,6-dichloro-4-trifluoromethylphenyl)- 4-(4,5-dicyano-lH-imidazol-2-yl)-lH-pyrazole, m.p. 119-123°. (Compound 18a).
Example 19
In a manner similar to that described in Example 6,
3-[ (2-amino-l,2-dicyanoethenylimino)methyl]- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-methoxy- lH-pyrazole, (see preparation of starting material for compound It was reacted with N-chlorosuccinimide/ nicotinamide to give 5-chloro-l-(2,6-dichloro-4-trifluoro¬ methylphenyl)-3-(4 ,5-dicyano-lH-imidazol-2-yl)-4-methoxy- lH-pyrazole, m.p. 247-52° (Compound 19a) .
Example 20
In a manner similar to that described in the preparation of—the-star-ting -material for compound Hi, -reaction of tert-butyl nitrite/bromoform with
(i) Compound 7a gave 5-bromo-l-(2,6-dichloro-4-trifluoro¬ methylphenyl)-3-(4,5-dicyano-lH-imidazol-2-yl)-4-ethoxy- carbonyl-lH-pyrazole, m.p. 230-1° (Compound 20a) . and (ii) Compound 7c gave 5-bromo-l-(2,6-dichloro-4-trifluoro¬ methylphenyl)-4-cyano-3-(4,5-dicyano-lH-imidazol-2-yl)- lH-pyrazole, m.p. 330-1° (Compound 20b) .
Example 21
Triethylamine (1.4 g) was added dropwise to a stirred mixture of 2-[ (chloro) (2,6-dichloro-4-trifluoromethyl- phenylhydrazono)methyl]-4,5-dicyano-lH-imidazole (5.5 g) , fumaronitrile (2.1 g) , chloroform (100 ml) and silver acetate (2.5 g) . The mixture was heated under reflux 5 hours and then subjected to flash column chromatography to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-cyano- 3-(4,5-dicyano-lH-imidazol-2-yl)-lH-pyrazole, m.p. 308-9° (Compound 21a) .
Example 22 tert-Butyl nitrite (3 ml) was added dropwise to a mixture of compound 7c (3 g) and copper (II) chloride (2 g) in acetonitrile (100 ml) . The mixture was stirred overnight at room temperature, poured into dilute hydrochloric acid and extracted with ethyl acetate. The extract was dried and evaporated and the residue worked up to give 5-chloro- 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-cyano- 3-(4,5-dicyano-lH"-imidazol-2-yl)-lH-pyrazole, m.p. >300° (dec) (Compound 22a).
Example 23
An ethereal solution of compound ly was washed with saturated aqueous sodium hydrogen carbonate and the mixture worked-up to~giw-the sodium-sa±t~σf-δ-^chloro- 1-(2 ,6-dichloro-4-trifluoromethylphenyl)-3-(4 ,5-dicyano- lH-i idazol^-ylJ-lH-pyrazole, m.p. 320°. (Compound 23a).
Example 24
A mixture of compound lz (2.15 g) and tetrabutylammonium fluoride (2.6 g) in tetrahydrofuran (50 ml) was stirred a room temperature for 20 minutes. It was poured into 2M hydrochloric acid and extracted with ether. The extract was dried and evaporated and the residue worked up to give 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-(4,5-dicyano- lH-imidazol-2-yl)-4-hydroxy-lH-pyrazole, m.p. 136-140°. (Compound 24a) . Example 25
Compound 24 was brominated using N-bromosuccinimide in a similar manner to that described for the preparation of the starting material of Example In to give 5-bromo-
1-(2,6-dichloro-4-trifluoromethylphenyl)-3-(4,5-dicyano- lH-imidazol-2-yl)-4-hydroxy-lH-pyrazole, m.p. 136-9°.
(Compound 25a) .
Test Examples
Compounds are assessed for activity against one or more of the following:
Lucilia sericata (sheep blow fly) a) contact test (LS) b) systemic test (LSS) Boophilus icroplus (blue tick) a) injection test (BMI) Musca domestica (house fly) a) contact test (MD)
Blattella germanica (cockroach) a) contact test (BG) b) bait test (BGB) Helminths a) Trichostrongylus colubriformis (TC) b) Heligmosomoides polygyrus (HP)
The tests are carried out as follows:
(Lucilia sericata. - contact test
1 ml aliquots of acetone solutions or suspensions, containing test compound at various concentrations, are applied to cotton wool dental rolls (1 cm x 2 cm) , contained in glass vials 2 cm diameter x 5 cm long. After drying, the treated materials are then impregnated with 1 ml of nutrient solution, infested with approximately 30 first instar larvae of sheep blow fly (Lucilia sericata) , closed by a cotton wool plug and held at 25°C for 24 hours. The activity is then assessed in comparison to controls. Compounds are considered active if the LC50 is less than 300 ppm.
(Lucilia sericata) - systemic test
100 mg of test compound are dissolved in 0.2 ml dimethyl sulfoxide and diluted with corn oil to the desired concentration. Approx 0.25 ml doses are fed to male mice, using 5 mice for each dose. 4 hours after treatment the mice are killed with carbon dioxide and the upper parts of hind legs removed and skinned. These are placed individually into sample tubes which are infested with first instar larvae of sheep blow fly (Lucilia sericata) , closed by a cotton wool plug and held at 25° for 24 hours. The activity is then assessed in comparison to controls. Compounds are considered active if the LC50 is less than 100 mg/kg of mouse.
.Boophilus microplus)
Test compounds are dissolved in a suitable solvent to a desired concentration. Using a microapplicator, 2 microlitres of the solution are injected into the blood filled stomach of a tick (Boophilus microplus.. 5 replicate ticks are treated at each concentration and subsequently each tick is retained separately in partitioned petri dish held at 25°C and >80% R.H. , until mortality of ticks or fecundity and viability of eggs produced by survivors can be assessed. The percentage reduction in total reproductive capacity (i.e. the combined effects of adult mortality, reduced fecundity and mortality of eggs) is then recorded and compared with controls. Compounds are considered active if they result in at least 50% reduction of reproductive capacity at a concentration of 20 microgram/tick or less.
Musca domestica
Aliquots (0.7 ml) of acetone solutions or suspensions of test compounds at various concentrations are applied to filter papers (9 cm diameter) placed in the bottom of petri dishes (9 cm diameter) closed by glass lids. After evaporation of solvent, the treated surfaces, together with controls treated with acetone alone, are then infested with adult houseflies, (Musca domestica) and held at 22°C for 24 hours. The percentage mortality of the insects is then recorded. Compounds are considered active if the LC50 is less than 1000 mg/m2.
Blattella germanica - contact test
Aliquots (1 ml) of solutions or suspensions of test compounds in a suitable solvent at various concentrations are applied to glass plates (10cm x 10cm) . After evaporation of solvent, the treated surfaces, together with controls treated with solvent alone, are infested with approximately 10 first instar nymphs of the German cockroach, (Blattella germanica) , retained on the treated surface within PTFE-coated glass rings 6 cm in diameter and held for 24 hours at 25°C. The percentage mortality of the insects is then recorded. Compounds are considered active if the LC50 is less than 100 mg/m2.
Blattella germanica - bait test
First/second instar nymphs of the German cockroach,
(Blattella germanica) are placed on glass plates and retained within glass rings. The nymphs are fed a diet of the test peanut butter/flour bait containing the test compound at various concentrations. The percentage mortality of the insects after 6 days is then recorded. Compounds are considered active if the LC50 is less than 1000 ppm.
Anthelmintic test a) Trichostrongylus colubriformis
Adult worms of the parasitic nematode Trichostrongylus colubriformis are cultured in multi-well plates containing sterile culture medium and test compound at a concentration of 100 ppm. The cultures are maintained in a sterile carbon dioxide incubator at 37°, at a constant air/carbon dioxide ratio of 95:5 (v/v). After 5 days the mortality is assessed in comparison with controls. Compounds are considered active if the LC50 is less than 100 ppm.
b) Heligmosomoides polygyrus
Groups of five mice are infected orally with 100 infective stage larvae (L3) of the murine gastrointestinal nematode Heligmosomoides polygyrus. After six days the mice are orally dosed with 50 μl of the test compound at the desired concentration in a carrier solution containing 1% wetter and 0.05% ethyl cellulose. A control group receives carrier only. After 7 days the mice are killed and the small intestine examined for worm count. Compounds are considered active if they give >50% worm reduction compared with the controls at a rate of 100 mg/kg mouse body weight.
Activities were demonstrated as follows (+ = active) ,
Compound LS LSS BMI MD BG BGB TC HP
No
+ +
+ + + +
+ + + + + +
+ + +
+
+ + +
+
Figure imgf000076_0001
Compound LS LSS BMI MD BG BGB TC HP No
+ +
+ +
+ + + +
+ +
+ +
Figure imgf000077_0001
+

Claims

1. A compound of formula I
Figure imgf000078_0001
where Z is a nitrogen containing heterocycle of formula
Z1, z2. z3, Z4 or Z5
Figure imgf000078_0002
(Z1) (Z2)
Figure imgf000078_0003
Ar Ar
(Z3) (Z4)
Figure imgf000078_0004
Ar (Z5) and salts thereof, in which Ar is aryl; V1 is N or CR9; V2 is N or CR10;
W1 is N or CR8;
W2 is N or CR11 ; except W1 and W2 are not both N; W3 is 0, S, NR40 or -CR1=CR42-; X is 0 or S; Y is 0, S or NR12;
W4 is C or can also be S when Y is 0; A is S(0)m, 0 or NR13;
R1 and R2 are hydrogen, optionally substituted alkyl, cyano, halogen or nitro; and R3 is hydrogen, optionally substituted alkyl, acyl, optionally substituted alkoxycarbonyl or sulfamoyl, R5 is hydrogen, halogen, optionally substituted alkyl, optionally substituted alkoxy, -NR16R17, cyano, nitro, S02NR16R17, CYNR16R17, COOR18 or R19S(0)m; R4 and R10, which may be the same or different, are hydrogen, halogen, hydroxy, mercapto, cyano, nitro, optionally substituted alkyl, optionally substituted alkoxy, -NR16R17, -S02NR16R17, CHO, CH20H, COOR18 or R19S(0)m; R6 is substituted alkyl, hydroxy, alkoxy, haloalkoxy, cyano, nitro, R19S(0)m or an N-linked 5-membered heteroaryl group containing 1-4 nitrogen atoms; and when R5 is cyano, -CYNR16R17, -COOR18, optionally substituted alkoxy, nitro, -NR16R17 or S02NR16R17, R6 can also be hydrogen, halogen, alkyl or -NR16R17; R7, R8 and R11, which may be the same or different, are hydrogen, halogen, optionally substituted alkyl or optionally substituted alkylthio; R9 is hydrogen, halogen, optionally substituted alkyl, formyl, optionally substituted alkoxy, aryl, cyano, nitro, hydroxy, trialkylsilyloxy, CYNR16R17, COOR18 or R19S(0)m;
R12 is hydrogen, optionally substituted alkyl or acyl; R13 is hydrogen, alkyl or acyl;
R16 and R17 are the same or different and are hydrogen, optionally substituted alkyl, acyl or aryl, or together with the nitrogen to which they are attached, form a 5 to 7 membered ring which can contain other hetero atoms; R18 is hydrogen or optionally substituted alkyl; R19 is optionally substituted alkyl;
R40 is hydrogen, optionally substituted alkyl or acyl; R41 and R42, which may be the same or different, are hydrogen or optionally substituted alkyl; and when V1 is CR9 and V2 is CR10, R9 and R4 together with the carbon atoms to which they are attached can form a six membered ring; and when V1 and V2 are both N, R4 can form a sulfur, nitrogen or carbon containing bridge to an ortho carbon atom on Ar; m is 0, 1 or 2; and p is 0 or 1, when Z is Z1 or Z2and is 0 when Z is Z3, Z4 or Z5.
2. A method of combating pests, especially insects, acarids or animal endoparasites, at a locus or host for the pest, infested or liable to be infested therewith, which comprises applying to the locus, host and/or the pest, a compound of formula I, as claimed in claim 1.
3. A pesticidal composition which comprises a compound a compound of formula I, as claimed in claim 1 in admixture with an agriculturally or veterinarily acceptable diluent or carrier.
4. A pharmaceutical composition which comprises a compound of formula I, as claimed in claim l in admixture with a pharmaceutically acceptable diluent or carrier.
PCT/GB1992/000233 1991-02-11 1992-02-10 Imidazole pesticides WO1992013451A1 (en)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
GB919102834A GB9102834D0 (en) 1991-02-11 1991-02-11 1,2,4-triazole pesticides
GB9102841.5 1991-02-11
GB9102857.1 1991-02-11
GB9102834.0 1991-02-11
GB919102835A GB9102835D0 (en) 1991-02-11 1991-02-11 Pyrrole pesticides
GB919102848A GB9102848D0 (en) 1991-02-11 1991-02-11 Pyrazole pesticides
GB919102847A GB9102847D0 (en) 1991-02-11 1991-02-11 Imidazole pesticides
GB9102847.2 1991-02-11
GB919102857A GB9102857D0 (en) 1991-02-11 1991-02-11 Pyrazole pesticides
GB9102835.7 1991-02-11
GB9102848.0 1991-02-11
GB9102838.1 1991-02-11
GB919102841A GB9102841D0 (en) 1991-02-11 1991-02-11 Imidazole pesticides
GB919102838A GB9102838D0 (en) 1991-02-11 1991-02-11 Pyrazole pesticides
GB919114712A GB9114712D0 (en) 1991-07-08 1991-07-08 Imidazole pesticides
GB9114712.4 1991-07-08
GB9117822.8 1991-08-17
GB919117822A GB9117822D0 (en) 1991-08-17 1991-08-17 Imidazole pesticides

Publications (1)

Publication Number Publication Date
WO1992013451A1 true WO1992013451A1 (en) 1992-08-20

Family

ID=27576340

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1992/000233 WO1992013451A1 (en) 1991-02-11 1992-02-10 Imidazole pesticides

Country Status (2)

Country Link
AU (1) AU1191292A (en)
WO (1) WO1992013451A1 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0585014A2 (en) * 1992-08-18 1994-03-02 Shionogi & Co., Ltd. Process for the preparation of 2,5-disubstituted imidazoles
WO1995025719A1 (en) * 1994-03-21 1995-09-28 Bayer Aktiengesellschaft N-aryl and n-alkylsulphonylaminals as pesticides
WO1996031123A1 (en) * 1995-04-05 1996-10-10 Rhone-Poulenc Agriculture Ltd. New method of combating insects
EP0846686A1 (en) * 1996-11-30 1998-06-10 Pfizer Limited 1-Phenyl-pyrazol derivatives and their use as parasiticidal agents
WO1998028279A1 (en) * 1996-12-24 1998-07-02 Rhone-Poulenc Agrochimie Pesticidal 1-aryl and pyridylpyrazole derivatives
WO1998028278A1 (en) * 1996-12-24 1998-07-02 Rhone-Poulenc Agrochimie Pesticidal 1-arylpyrazoles
WO1998039302A1 (en) * 1997-03-03 1998-09-11 Rhone-Poulenc Agro Processes for preparing pesticidal intermediates
EP0911329A1 (en) * 1997-10-07 1999-04-28 Rhone-Poulenc Agro 3-Substituted arylpyrazole derivatives
US5981565A (en) * 1997-10-07 1999-11-09 Rhone-Poulenc Inc. Pyrazole pesticides
EP0957094A1 (en) * 1998-05-14 1999-11-17 Pfizer Inc. 1-(2-Halogenaryl)azoles as antiparasitic agents
US6069157A (en) * 1997-11-25 2000-05-30 Pfizer Inc. Parasiticidal compounds
US6107314A (en) * 1997-10-07 2000-08-22 Rhone-Poulenc Inc. Pesticides
US6159980A (en) * 1996-09-16 2000-12-12 Dupont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
WO2001007413A1 (en) * 1999-07-22 2001-02-01 3-Dimensional Pharmaceuticals, Inc. 1-aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides
US6409988B1 (en) 1999-07-01 2002-06-25 3-Dimensional Pharmaceuticals, Inc. Radiolabeled 1-aryl pyrazoles, the synthesis thereof and the use thereof as pest GABA receptor ligands
US6500850B2 (en) 1996-12-24 2002-12-31 Rhone-Poulenc Inc. Pesticidal 1-arylpyrazoles
US6506784B1 (en) 1999-07-01 2003-01-14 3-Dimensional Pharmaceuticals, Inc. Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticides
US6545033B1 (en) 1999-10-06 2003-04-08 3-Dimensional Pharmaceuticals, Inc. Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides
WO2004035566A1 (en) * 2002-10-18 2004-04-29 Pfizer Products Inc. Cannabinoid receptor ligands and uses thereof
FR2869905A1 (en) * 2004-05-10 2005-11-11 Sanofi Synthelabo PROCESS FOR PREPARING ESTER OF 1,5-DIPHENYLPYRAZOLE CARBOXYLIC ACID
US20090318455A1 (en) * 2008-06-03 2009-12-24 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9051309B2 (en) 2013-03-15 2015-06-09 Monsanto Technology Llc 3,5-disubstituted-1,3,4-oxadiazol-2(3H)-ones and compositions and methods for controlling nematode pests
US9156837B2 (en) 2011-07-29 2015-10-13 Takeda Pharmaceutical Company Limited Heterocyclic compound
JPWO2014007228A1 (en) * 2012-07-03 2016-06-02 小野薬品工業株式会社 Compound having somatostatin receptor agonist activity and pharmaceutical use thereof
US9359379B2 (en) 2012-10-02 2016-06-07 Intermune, Inc. Anti-fibrotic pyridinones
US9527816B2 (en) 2005-05-10 2016-12-27 Intermune, Inc. Method of modulating stress-activated protein kinase system
US10112930B2 (en) 2007-08-13 2018-10-30 Monsanto Technology Llc Compositions and methods for controlling nematodes
US10233195B2 (en) 2014-04-02 2019-03-19 Intermune, Inc. Anti-fibrotic pyridinones

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT375933B (en) * 1979-04-10 1984-09-25 Ciba Geigy Ag METHOD FOR PRODUCING NEW 2-SUBSTITUTED MERCAPTOIMIDAZOLE DERIVATIVES AND THEIR SALTS
EP0284277A1 (en) * 1987-03-21 1988-09-28 AgrEvo UK Limited Cyanoimidazole fungicides
GB2214180A (en) * 1988-01-12 1989-08-31 Shell Int Research Pytotoxic pyrrole-3,4-dicarboxylate derivatives
EP0412849A2 (en) * 1989-08-10 1991-02-13 AgrEvo UK Limited Azole pesticides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT375933B (en) * 1979-04-10 1984-09-25 Ciba Geigy Ag METHOD FOR PRODUCING NEW 2-SUBSTITUTED MERCAPTOIMIDAZOLE DERIVATIVES AND THEIR SALTS
EP0284277A1 (en) * 1987-03-21 1988-09-28 AgrEvo UK Limited Cyanoimidazole fungicides
GB2214180A (en) * 1988-01-12 1989-08-31 Shell Int Research Pytotoxic pyrrole-3,4-dicarboxylate derivatives
EP0412849A2 (en) * 1989-08-10 1991-02-13 AgrEvo UK Limited Azole pesticides

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0585014A2 (en) * 1992-08-18 1994-03-02 Shionogi & Co., Ltd. Process for the preparation of 2,5-disubstituted imidazoles
EP0585014A3 (en) * 1992-08-18 1994-12-14 Shionogi & Co Process for the preparation of 2,5-disubstituted imidazoles.
WO1995025719A1 (en) * 1994-03-21 1995-09-28 Bayer Aktiengesellschaft N-aryl and n-alkylsulphonylaminals as pesticides
US5994389A (en) * 1994-03-21 1999-11-30 Bayer Aktiengesellschaft N-aryl- and N-alkylsulfonylaminals
WO1996031123A1 (en) * 1995-04-05 1996-10-10 Rhone-Poulenc Agriculture Ltd. New method of combating insects
AP849A (en) * 1995-04-05 2000-06-13 Rhone Poulenc Agriculture Use of phenylpyrazole derivatives for surface treatment to control cockroaches or ants.
US6218391B1 (en) 1996-09-16 2001-04-17 Dupont Pharmaceuticals Company Triazinones and derivatives thereof
US6159980A (en) * 1996-09-16 2000-12-12 Dupont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
EP0846686A1 (en) * 1996-11-30 1998-06-10 Pfizer Limited 1-Phenyl-pyrazol derivatives and their use as parasiticidal agents
US6156782A (en) * 1996-11-30 2000-12-05 Pfizer Inc Parasiticidal compounds
WO1998028279A1 (en) * 1996-12-24 1998-07-02 Rhone-Poulenc Agrochimie Pesticidal 1-aryl and pyridylpyrazole derivatives
US6500850B2 (en) 1996-12-24 2002-12-31 Rhone-Poulenc Inc. Pesticidal 1-arylpyrazoles
US6350771B1 (en) 1996-12-24 2002-02-26 Rhone-Poulenc, Inc. Pesticidal 1-arylpyrazoles
US6638956B2 (en) 1996-12-24 2003-10-28 Rhone-Poulenc, Inc. Pesticidal 1-arylpyrazoles
AP1039A (en) * 1996-12-24 2002-01-23 Rhone Poulenc Agrochimie Pesticidal 1-arylpyrazoles.
WO1998028278A1 (en) * 1996-12-24 1998-07-02 Rhone-Poulenc Agrochimie Pesticidal 1-arylpyrazoles
AP1004A (en) * 1996-12-24 2001-08-28 Rhone Poulenc Agrochimie Pesticidal 1-aryl and pyridylpyrazole derivatives.
US6084105A (en) * 1997-03-03 2000-07-04 Rhone-Poulenc Agro Processes for preparing pesticidal intermediates
WO1998039302A1 (en) * 1997-03-03 1998-09-11 Rhone-Poulenc Agro Processes for preparing pesticidal intermediates
US6258973B1 (en) 1997-03-03 2001-07-10 Rhone-Poulenc Agro Processes for preparing pesticidal intermediates
US6500848B2 (en) 1997-10-07 2002-12-31 Rhone-Poulenc Inc. Pesticides
US6593328B2 (en) 1997-10-07 2003-07-15 Rhone-Poulenc Inc. Pesticides
US6277848B1 (en) 1997-10-07 2001-08-21 Rhone-Poulenc, Inc. Pesticides
US6107314A (en) * 1997-10-07 2000-08-22 Rhone-Poulenc Inc. Pesticides
US6346522B1 (en) 1997-10-07 2002-02-12 Rhone-Poulenc, Inc. Pesticides
US6376520B1 (en) 1997-10-07 2002-04-23 Rhone-Poulenc, Inc. Pesticides
EP0911329A1 (en) * 1997-10-07 1999-04-28 Rhone-Poulenc Agro 3-Substituted arylpyrazole derivatives
US6432997B1 (en) 1997-10-07 2002-08-13 Rhone-Poulenc, Inc. Pyrazole pesticides
US5981565A (en) * 1997-10-07 1999-11-09 Rhone-Poulenc Inc. Pyrazole pesticides
US6069157A (en) * 1997-11-25 2000-05-30 Pfizer Inc. Parasiticidal compounds
EP0957094A1 (en) * 1998-05-14 1999-11-17 Pfizer Inc. 1-(2-Halogenaryl)azoles as antiparasitic agents
US6506784B1 (en) 1999-07-01 2003-01-14 3-Dimensional Pharmaceuticals, Inc. Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticides
US6409988B1 (en) 1999-07-01 2002-06-25 3-Dimensional Pharmaceuticals, Inc. Radiolabeled 1-aryl pyrazoles, the synthesis thereof and the use thereof as pest GABA receptor ligands
US6518266B1 (en) 1999-07-22 2003-02-11 3-Dimensional Pharmaceuticals 1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides
WO2001007413A1 (en) * 1999-07-22 2001-02-01 3-Dimensional Pharmaceuticals, Inc. 1-aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides
US6545033B1 (en) 1999-10-06 2003-04-08 3-Dimensional Pharmaceuticals, Inc. Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides
WO2004035566A1 (en) * 2002-10-18 2004-04-29 Pfizer Products Inc. Cannabinoid receptor ligands and uses thereof
FR2869905A1 (en) * 2004-05-10 2005-11-11 Sanofi Synthelabo PROCESS FOR PREPARING ESTER OF 1,5-DIPHENYLPYRAZOLE CARBOXYLIC ACID
US9527816B2 (en) 2005-05-10 2016-12-27 Intermune, Inc. Method of modulating stress-activated protein kinase system
US10010536B2 (en) 2005-05-10 2018-07-03 Intermune, Inc. Method of modulating stress-activated protein kinase system
US10827753B2 (en) 2007-08-13 2020-11-10 Monsanto Technology Llc Compositions and methods for controlling nematodes
US10375958B2 (en) 2007-08-13 2019-08-13 Monsanto Technology Llc Compositions and methods for controlling nematodes
US10112930B2 (en) 2007-08-13 2018-10-30 Monsanto Technology Llc Compositions and methods for controlling nematodes
US8304413B2 (en) * 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US8969347B2 (en) 2008-06-03 2015-03-03 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US20090318455A1 (en) * 2008-06-03 2009-12-24 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
USRE47142E1 (en) 2008-06-03 2018-11-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9290450B2 (en) 2008-06-03 2016-03-22 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9156837B2 (en) 2011-07-29 2015-10-13 Takeda Pharmaceutical Company Limited Heterocyclic compound
US9975904B2 (en) 2012-07-03 2018-05-22 Ono Pharmaceutical Co., Ltd. Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes
US10214540B2 (en) 2012-07-03 2019-02-26 Ono Pharmaceutical Co., Ltd. Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes
JPWO2014007228A1 (en) * 2012-07-03 2016-06-02 小野薬品工業株式会社 Compound having somatostatin receptor agonist activity and pharmaceutical use thereof
US9675593B2 (en) 2012-10-02 2017-06-13 Intermune, Inc. Anti-fibrotic pyridinones
US10376497B2 (en) 2012-10-02 2019-08-13 Intermune, Inc. Anti-fibrotic pyridinones
US9359379B2 (en) 2012-10-02 2016-06-07 Intermune, Inc. Anti-fibrotic pyridinones
US10898474B2 (en) 2012-10-02 2021-01-26 Intermune, Inc. Anti-fibrotic pyridinones
US9051309B2 (en) 2013-03-15 2015-06-09 Monsanto Technology Llc 3,5-disubstituted-1,3,4-oxadiazol-2(3H)-ones and compositions and methods for controlling nematode pests
JP2016520522A (en) * 2013-03-15 2016-07-14 モンサント テクノロジー エルエルシー N-, C-disubstituted azoles for nematode pest control
US10233195B2 (en) 2014-04-02 2019-03-19 Intermune, Inc. Anti-fibrotic pyridinones
US10544161B2 (en) 2014-04-02 2020-01-28 Intermune, Inc. Anti-fibrotic pyridinones

Also Published As

Publication number Publication date
AU1191292A (en) 1992-09-07

Similar Documents

Publication Publication Date Title
WO1992013451A1 (en) Imidazole pesticides
US5109012A (en) 2-imidazol(in)e substituted aryl-1,2,3-triazole pesticides
US6350771B1 (en) Pesticidal 1-arylpyrazoles
US5523280A (en) Phenylpyrazole fungicides
EP0665225B1 (en) 4-Phenethylamino pyrimidine derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same
US4663339A (en) Acaricidal and insecticidal substituted 1-phenylalkylbenzimidazoles
JP2008044880A (en) Insecticidal isooxazolines
SI9300220A (en) Fungicidal arylpyrazole derivatives
JP2006076990A (en) Insecticidal benzenedicarboxamide compounds
AP103A (en) Triazole insecticides
CA2087260A1 (en) Herbicidal substituted aryl alkylsulfonyl pyrazoles
US5965491A (en) Pesticidal 1-aryl-3-iminopyrazoles
US5691333A (en) Pesticidal 1-arylpyrazole-3-carboximidothoic acid esters
US4803215A (en) 5-Heterocyclyl-1-aryl-pyrazoles, composition containing them, and method of using them to combat insects, acarids and nematodes
JPH0723362B2 (en) Pyrazole derivative, method for producing the same, herbicide and insecticide
US6107322A (en) Pesticidal 1-polyarylimidazoles
WO1995004724A1 (en) Imidazole derivative, process for producing the same, and pest control drug
JPS62283961A (en) 5-oxy(thio)pyrazole derivative
US5189053A (en) Imidazol(in)e substituted haloarylpyrazole pesticides
DD298101A5 (en) SUBSTITUTED ARYLTRIAZOLE AND THEIR USE AS PESTICIDES
JP2021507911A (en) Fluoralkenyl compounds, their production methods and their use
EP0286006B1 (en) Thiadiazole derivative, and insecticidal and miticidal composition containing the derivative as the effective ingredient
JPH07258223A (en) 4-phenethylaminopyrimidine derivative, its production and noxious life controlling agent for agricultural and horticultural use
US6638956B2 (en) Pesticidal 1-arylpyrazoles
JPH0776577A (en) Diphenyltriazole derivative and insecticide and acaricide

Legal Events

Date Code Title Description
LE Later election for international application filed prior to expiration of 19th month from priority date

Free format text: CS

AK Designated states

Kind code of ref document: A1

Designated state(s): AU BG BR CA CS FI HU JP KR PL RO RU SD US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: CS

LE Later election for international application filed prior to expiration of 19th month from priority date

Free format text: CS

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA